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Abstract
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Toxicology

Investigation of Docosahexaenoic Acid as a Potential Treatment for Particulate-Induced
Inflammation
Chairperson: Holian, Andrij, Ph.D.
Acute and chronic inflammation are vital contributing factors to pulmonary
diseases which can be triggered by the exposure to airborne toxicants such as crystalline
silica (SiO2) and nanomaterials. There has been an increasing trend in the use of
nanomaterials; specifically multi-walled carbon nanotubes (MWCNT), in various
consumer products that in turn will increase the risk of pulmonary diseases. Unfortunately,
there is a lack of preventative and therapeutic treatments for these diseases. A potential
treatment that has been shown to have anti-inflammatory effects is the common dietary
supplement docosahexaenoic acid (DHA); an omega-3 polyunsaturated fatty acid most
commonly found in fish oil. However, the anti-inflammatory mechanisms of DHA are
unclear in regard to particle-induced inflammation. Macrophages are important regulators
in an immune response to inhaled foreign materials, such as SiO2 and MWCNT, in order
to maintain homeostasis. Exposure to various particles can cause phagolysosomal
membrane permeability (LMP) within macrophages which activates the NLRP3
inflammasome resulting in inflammation. Macrophage functions are dependent upon
various signaling factors which generate different macrophage phenotypes described
broadly as classically activated, “pro-inflammatory” M1 and alternatively activated, “antiinflammatory” M2 as well as the additional M2 subsets. Signaling factors determine which
macrophage phenotype is dominant to regulate the overall response to foreign particles.
This research investigated DHA as both a prophylactic and a therapeutic treatment for
particle-induced inflammation. The mechanisms by which DHA functions as an antiinflammatory dietary supplement in regard to particle-induced inflammation were assessed
by characterizing the impact of DHA on macrophage phenotypes and LMP.

ii

Acknowledgements
Thank you to the Center for Environmental Health Sciences and the Department of
Biomedical & Pharmaceutical Sciences for giving me the opportunity to further my
research career. I would like to express my gratitude to my mentor, Dr. Andrij Holian, and
my committee members for your support and valuable insight throughout these past 5
years. A special thank you to the CEHS research staff for training me on different
techniques and answering all of my questions – Britt Postma, Mary Buford French, Fred
Rhoderick, Ray Hamilton, Lou Herritt, and Pam Shaw. Thank you to members of the
Holian laboratory group and other laboratories within CEHS; especially to the graduate
students for your encouragement and friendship.
Thank you to the University of Montana and for federal funding to allow us to perform the
research that we do. I am honored and incredibly grateful to have received the Ruth L.
Kirschstein National Research Service Award Pre-doctoral Fellowship from the National
Institute of Environmental Health Sciences (F31 ES028100). This Fellowship gave me the
opportunity to develop a customized research project and to attend various research
training opportunities for me to become a better scientific researcher.
None of this would have been accomplished without the unwavering love and support (both
near and far) from my family and friends. I am deeply grateful to my parents Wayne and
Beverly Fletcher, my sister Jeni Fletcher, my brother Brock Fletcher, my sister-in-law
Jessica Fletcher, my nephews Jace and Wyatt, and my friend Michelle Contreras for always
being there for me, no matter the distance or time of day. To the French Family – Mary,
Brian, Mia, and Susannah, thank you for welcoming me into your lives and making me a
part of your family. A special thank you to both Mary and Fred for your lifelong
friendships. Lastly, to Mr. Cash for helping me keep my sanity.

Additional Acknowledgements:
Please refer to the end of Chapters 3, 4, and 5 for acknowledgements specific to each
research project.

iii

Table of Contents
Abstract.............................................................................................................................. ii
Acknowledgements .......................................................................................................... iii
List of Figures ................................................................................................................... vi
List of Tables .................................................................................................................. viii
1. Introduction and Significance ...................................................................................... 1
1.1 Particle exposure and disease................................................................................ 1
1.2 Polyunsaturated fatty acids ................................................................................... 2
1.2.1 Docosahexaenoic acid (DHA) ....................................................................... 3
1.3 Phagolysosomal membrane permeability (LMP) ................................................. 4
1.4 Macrophage phenotype ......................................................................................... 5
1.5 Research motivation.............................................................................................. 7
2. Materials and Methods ................................................................................................. 9
2.1 in vitro experimental procedures .......................................................................... 9
2.1.1 Particle Preparations ...................................................................................... 9
2.1.2 Isolation of Alveolar Macrophages ................................................................ 9
2.1.3 Cell Culture and Polarization of Macrophage Phenotypes .......................... 10
2.1.4 Cytotoxicity Assays ..................................................................................... 11
2.1.5 Particle Uptake & Flow Cytometry ............................................................. 11
2.1.6 Phagolysosomal Membrane Permeability (LMP) Assay ............................. 12
2.2 in vivo experimental procedures ......................................................................... 13
2.2.1 Particle Preparations .................................................................................... 13
2.2.2 Mice and Diets ............................................................................................. 13
2.2.3 Experimental Designs .................................................................................. 16
2.2.4 Isolation of Pulmonary Cells ....................................................................... 16
2.2.5 Analysis of Cell Damage and Inflammatory Mediators .............................. 17
2.2.6 Macrophage Phenotype Analysis ................................................................. 17
2.2.7 Histopathology ............................................................................................. 19
2.3 Statistical Analysis .............................................................................................. 20
3. DHA impacts macrophage phenotype and LMP with particle exposure in vitro and
an acute particle exposure in vivo .................................................................................. 21
3.1 Abstract ............................................................................................................... 21
3.2 Introduction ......................................................................................................... 22
3.3 Results ................................................................................................................. 24
3.3.1 Cytotoxicity assessments of DHA in vitro................................................... 24
3.3.2 Effects of DHA on IL-1β release in vitro .................................................... 29
3.3.3 Effect of DHA on particle uptake and LMP in vitro ................................... 31
3.3.4 Effect of DHA on lung injury and inflammation in vivo ............................. 35
iv

3.3.5 DHA’s effect on pulmonary cells in vivo .................................................... 42
3.3.6 Alteration of macrophage phenotype by DHA in vivo ................................ 44
3.3.7 Effect of DHA on lung histopathology in vivo ............................................ 47
3.4 Discussion ........................................................................................................... 49
3.5 Acknowledgments............................................................................................... 55
4. DHA as a potential prophylactic treatment for semi-acute and chronic particleinduced inflammation in vivo ......................................................................................... 57
4.1 Abstract ............................................................................................................... 57
4.2 Introduction ......................................................................................................... 58
4.3 Results ................................................................................................................. 60
4.3.1 Effect of DHA on pulmonary cells and lung injury ..................................... 60
4.3.2 Alteration of LMP due to DHA ................................................................... 71
4.3.3 DHA shifts macrophage phenotype ............................................................. 74
4.3.4 Effect of DHA on lung histopathology ........................................................ 79
4.4 Discussion ........................................................................................................... 81
4.5 Acknowledgments............................................................................................... 87
5. DHA as a potential therapeutic treatment for semi-acute and chronic particleinduced inflammation in vivo ......................................................................................... 89
5.1 Abstract ............................................................................................................... 89
5.2 Introduction ......................................................................................................... 90
5.3 Results ................................................................................................................. 92
5.3.1 Effect of DHA on pulmonary cells and lung injury ..................................... 92
5.3.2 Alteration of LMP due to DHA ................................................................. 103
5.3.3 DHA shifts macrophage phenotype ........................................................... 107
5.3.4 Effect of DHA on lung histopathology ...................................................... 112
5.4 Discussion ......................................................................................................... 115
5.5 Acknowledgments............................................................................................. 120
References ...................................................................................................................... 121

v

List of Figures
Figure 1. Comparing BSA and EtOH as DHA vehicle in vitro ........................................ 26
Figure 2. Lactate dehydrogenase (LDH) analysis of macrophage phenotypes in vitro .. 28
Figure 3. IL-1β release of macrophage phenotypes in vitro ............................................ 30
Figure 4. Particle uptake of macrophage phenotypes in vitro ......................................... 32
Figure 5. LMP analysis of macrophage phenotypes in vitro ........................................... 34
Figure 6. Experimental design of prophylactic acute model ........................................... 36
Figure 7. Fatty acid analysis within red blood cells in prophylactic acute model .......... 38
Figure 8. Assessment of lung damage and cytokine analysis within the LLF for
prophylactic acute model .......................................................................................... 40
Figure 9. Analysis of cell types within LLF for prophylactic acute model ...................... 41
Figure 10. Assessment of LMP for prophylactic acute model.......................................... 43
Figure 11. Impact of particle exposure and DHA treatment on macrophage phenotype for
prophylactic acute model .......................................................................................... 45
Figure 12. Histopathology analysis of lung tissue for prophylactic acute model ............ 48
Figure 13. Experimental designs of prophylactic semi-acute & chronic models ................. 61
Figure 14. Fatty acid analysis within red blood cells of prophylactic semi-acute & chronic
models ........................................................................................................................ 63
Figure 15. Pulmonary cells and lung injury analysis in prophylactic semi-acute model 64
Figure 16. Cytokine analysis in prophylactic semi-acute model ..................................... 66
Figure 17. Pulmonary cells and lung injury analysis in prophylactic chronic model ..... 69
Figure 18. Cytokine analysis in prophylactic chronic model ........................................... 70
Figure 19. Assessment of LMP in prophylactic semi-acute model .................................. 72
vi

Figure 20. Assessment of LMP in prophylactic chronic model........................................ 73
Figure 21. Impact of particle exposure and DHA treatment on macrophage phenotype in
prophylactic semi-acute model ................................................................................. 76
Figure 22. Impact of particle exposure and DHA treatment on macrophage phenotype in
prophylactic chronic model ...................................................................................... 78
Figure 23. Histopathology analysis of lung tissue in prophylactic semi-acute model ..... 80
Figure 24. Histopathology analysis of lung tissue in prophylactic chronic model .......... 82
Figure 25. Experimental designs of therapeutic semi-acute & chronic models .............. 93
Figure 26. Fatty acid analysis within red blood cells for therapeutic semi-acute & chronic
models ....................................................................................................................... 96
Figure 27. Pulmonary cells and lung injury analysis in therapeutic semi-acute model .. 98
Figure 28. Cytokine analysis in therapeutic semi-acute model ....................................... 99
Figure 29. Pulmonary cells and lung injury analysis in therapeutic chronic model ..... 101
Figure 30. Cytokine analysis in therapeutic chronic model ........................................... 102
Figure 31. Assessment of LMP in therapeutic semi-acute model .................................. 104
Figure 32. Assessment of LMP in therapeutic chronic model........................................ 106
Figure 33. Impact of particle exposure and DHA treatment on macrophage phenotype in
therapeutic semi-acute model ................................................................................. 109
Figure 34. Impact of particle exposure and DHA treatment on macrophage phenotype in
therapeutic chronic model ...................................................................................... 111
Figure 35. Histopathology analysis of lung tissue in therapeutic semi-acute model ..... 113
Figure 36. Histopathology analysis of lung tissue in therapeutic chronic model .......... 114

vii

List of Tables
Table 1. Formulations of experimental diets ................................................................... 15
Table 2. Fatty acid composition of red blood cells in prophylactic acute model ............ 37
Table 3. Fatty acid composition of red blood cells in prophylactic semi-acute model.... 62
Table 4. Fatty acid composition of red blood cells in prophylactic chronic model ......... 67
Table 5. Fatty acid composition of red blood cells in therapeutic semi-acute model...... 94
Table 6. Fatty acid composition of red blood cells in therapeutic chronic model ........... 95

viii

Chapter 1
Introduction and Significance

1.1 Particle exposure and disease
More than one billion people worldwide suffer from either acute or chronic respiratory
conditions which leads to respiratory diseases making up 5 of the 30 most common causes
of death. Over one billion people inhale polluted outdoor air; therefore, contributing to this
respiratory impairment (Forum of International Respiratory Societies, 2017). It is known
that exposure to airborne toxicants can cause acute and chronic inflammation within the
lungs which can lead to serious inflammatory diseases; such as lung fibrosis, and contribute
to autoimmune diseases (Wong et al., 2016). Many occupational and man-made particles
of specific concern have a diameter of less than 2.5 µm and can travel down into the
alveolar regions of the lung when inhaled. These include various engineered nanomaterials
(ENM); such as multi-walled carbon nanotubes (MWCNT), and crystalline silica (SiO 2).
The use of ENM has been rapidly increasing in many commercial products; such
as cosmetics, electronics, and medicine (Ray et al., 2019). One of the most common ENM
used for these products are MWCNT which are nano-sized, meaning that it has at least one
dimension (length, width, diameter) in the size range of 1–100 nm (Yokel & MacPhail,
2011). MWCNT are hydrophobic man-made rolled graphene sheets that have a high
surface area per mass (Saifuddin et al., 2013). However, some MWCNT have been linked
to lung fibrosis similar to that produced by chrysotile asbestos as well as granuloma
formations ( Yokel & MacPhail, 2011; Lam et al., 2006).
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In contrast to the nanosized MWCNT, SiO 2 is a micron-sized particle primarily
generated in occupational settings such as mining, manufacturing, and construction. It is
considered hydrophilic and commonly found in nature as quartz which can be fractured to
a respirable size of <10 μm (Dyachenko et al., 2004; Pollard, 2016). Exposure to inhalable
SiO2 particles are known to cause silicosis; an established world-wide occupational health
problem, and autoimmune disorders (Pollard, 2016). Understanding the mechanisms of
lung inflammation and the development of preventative and therapeutic treatments to
reduce inflammation caused by either of these particles are currently lacking within this
field.

1.2 Polyunsaturated fatty acids
Two important families of polyunsaturated fatty acids (PUFA) are omega-6 and omega-3.
Foods high in omega-6 PUFAs are vegetable oils, red meat, and dairy. Omega-3 PUFAs
are high in salmon, tuna, and walnuts. Omega-6 and omega-3 PUFAs encompass the
essential fatty acids of linoleic and α-linolenic acids; respectively. These two fatty acids
are considered to be essential since they cannot be synthesized in animals. (Calder, 2017;
Molendi-Coste et al., 2011; Swanson et al., 2012). These essential fatty acids are converted
into other fatty acids within each PUFA family such as arachidonic (ARA) and
docosahexaenoic (DHA) acids through various desaturation and elongation steps (Calder,
2017).
The linoleic essential fatty acid is usually the most prevalent PUFA in the human
diet partly due to the fact that plants produce much more of it than of α-linolenic acid.
Unfortunately, in most Western diets there is too much omega-6; in part due to high levels
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of consumption of red meat, and not enough of omega-3 which can be improved with
consumption of fatty fish. This diet leads to an omega-6/-3 ratio of 10-20/1 where most
adults intake less than 0.2 g/day of DHA (Calder, 2017; Molendi-Coste et al., 2011).
Increased ARA content is linked to inflammation while exposure to omega-3 PUFAs;
specifically DHA, has been shown to have various anti-inflammatory capabilities (Calder,
2017; Swanson et al., 2012).

1.2.1 Docosahexaenoic acid (DHA)
It has been reported that there has been a 60% increase between 2007 and 2012 in the
dietary intake of fish oil supplementation which is high in DHA (Clarke et al., 2015). DHA
is a long-chain, highly unsaturated omega-3 fatty acid that consists of 22 carbons and 6 cis
double bonds (22:6). This allows the structure of DHA to twist, resulting in a low melting
point. It is often found linked into a more complex lipid structure, such as a phospholipid.
DHA is an important component of all cell membranes and is mainly found in the brain
and retina (Calder, 2016).
Studies have shown that DHA is beneficial throughout life; such as improving
cognitive capabilities during fetal development and improving outcomes for cardiovascular
disease and Alzheimer’s disease (Devassy et al., 2016; Swanson et al., 2012). However,
assessing the impact of DHA as a potential treatment in regard to particle-induced
inflammation is limited. Evidence has suggested that omega-3 PUFAs decreased particleinduced inflammation in both C57BL/6 wild-type mice; which are Th1-prone, and in a
transgenic Fat-1 murine model with a C57BL/6 background (X.-Y. Li et al., 2017;
Watanabe et al., 2004). It has also been shown that DHA blocked SiO2-triggered
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autoimmunity in autoimmune disease-prone NZBWF1 mice (Bates et al., 2016). The antiinflammatory mechanisms of DHA in regard to particle-induced inflammation within a
Balb/c murine model; which are Th2-prone (Watanabe et al., 2004), are not fully
understood.

1.3 Phagolysosomal membrane permeability (LMP)
Pulmonary macrophages are responsible for maintenance of homeostatic conditions within
the lungs. This includes regulating immune responses to inhaled foreign materials; such as
exposure to MWCNT or SiO2, by phagocytosing these foreign substances and processing
them for elimination. Macrophages can’t clear these particles and their persistence in the
lung can lead to inflammation that can progress to fibrosis and systemic diseases (Byrne et
al., 2015). Inflammation induced by macrophages is initiated by activation of two signals:
1) the NF-B pathway and 2) the NLRP3 inflammasome (Schroder & Tschopp, 2010).
The first signal is responsible for priming the cell. Various pathogen-associated
molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) can
trigger activation of the NF-B pathway. NF-B is responsible for the formation of proIL-1 and components of the NLRP3 inflammasome (Lamkanfi & Dixit, 2014; MartínezMicaelo et al., 2016; Schroder & Tschopp, 2010). This is an essential step; however, the
current research focuses more on the second signal in regard to particle-induced
inflammation.
The activation signal is the second signal which promotes conformational changes
to prompt the assembly of the NLRP3 inflammasome. There is a cascade of events that
occurs before activation of signal 2. Particles are phagocytosed by alveolar macrophages
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(AM) and become engulfed in a phagosome which comes together with a lysosome to form
a phagolysosome. This phagolysosome is where foreign material is intended to be degraded
in order to maintain homeostasis. However, non-degradable particles, such as MWCNT
and SiO2, can cause phagolysosomal membrane permeability (LMP). The occurrence of
LMP leads to the release of various proteases into the cytosol; such as cathepsins and
cathepsin B in particular. Cathepsin B has been reported to activate the NLRP3
inflammasome which in turn cleaves pro-caspase-1 into active caspase-1 causing pro-IL1 processing into its mature form of IL-1 for secretion. This results in various
inflammatory signaling cascades to ensue (Lamkanfi & Dixit, 2014; Martínez-Micaelo et
al., 2016; Schroder & Tschopp, 2010; Strowig et al., 2012).

1.4 Macrophage phenotype
Macrophages are phenotypically complex and subject to their environment, such that their
functions and contribution to inflammation are dependent upon various signaling factors.
These stimuli; both intercellular and extracellular signaling, determine which macrophage
phenotype is dominant to regulate the overall response to foreign particles. Depending on
the overall environment present during particle exposure, macrophages could either be
aiding in inflammation or suppressing inflammation through phenotype shifts. There is
always a mixture of macrophage phenotypes present which could be representing hybrid
phenotypes rather than individually-defined phenotypes; however, the overall response is
expected to be based upon the dominant phenotype (Byrne et al., 2015; Italiani & Boraschi,
2014; Labonte et al., 2014).
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The most common paradigm is the “M” classification which was named to reflect
the Th1/Th2 polarization. There are two main phenotypes of macrophages that are broadly
defined as the classically activated, “pro-inflammatory” M1 and the alternatively activated,
“anti-inflammatory” M2. The M2 phenotype also has additional subsets of M2a, M2b,
M2c, and M2d (Labonte et al., 2014). Most research assesses the roles of the M1 and M2a
phenotypes. The M1 phenotype is considered a Th1-like response with type I
inflammation. It is induced by IFNγ or LPS and express high levels of IL-12, iNOS, IL-1β
and TNFα. The M2a phenotype is considered more of a Th2-like response with type II
inflammation and allergy. It is induced by IL-4 or IL-13 and express high levels of YM1,
CD206, and FIZZ1. All of the M2 subsets have overlapping similarities of a Th2-like
response and produce high levels of IL-10; however, they are individually complex. The
M2b phenotype has overlapping characteristics with the M1 phenotype as well and is
labeled as “type II – activated”. It is induced by immune complexes and TLR/IL-1R ligands
and express high levels of CCL1, LIGHT, and SPHK1. The M2c phenotype is labeled as
“deactivated” with overlapping characteristics with the M2a phenotype and is involved in
matrix deposition and tissue remodeling. It is induced by IL-10, TGF-β, or glucocorticoids
and produce high levels of CD163, TLR8, and TGF-β. There is also the M2d subset which
is labeled as “tumor-associated macrophages” (TAMs) and have high levels of VEGF
which promotes tumor growth and metastasis. (Tomioka, 2016; Jiang & Zhu, 2016;
Hesketh et al, 2017; Mantovani et al, 2004).
Understanding the contributions of the M1 and M2 macrophage phenotypes is
crucial to assessing the inflammatory effects of particles since macrophages are an essential
cell that regulates the innate immune response to inhaled foreign particles. The actual
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contributions of M1 and M2 macrophages in disease progression are not fully established.
Furthermore, the mechanisms of the formation of the various M2 subsets, especially M2b
and M2c, are not well-defined in regard to particle-induced inflammation.

1.5 Research motivation
The objectives of the current studies were to evaluate the ability of DHA to reduce
pulmonary inflammation caused by MWCNT and SiO 2, both as a potential prophylactic
and a therapeutic treatment. The use of the two different particles provided the opportunity
to examine the effects of DHA on particles with reported differences in immune
mechanisms (Ray et al., 2019) within time courses that represented both moderate and high
levels of particle doses. A Balb/c murine model; which is considered more Th2 prone
(Watanabe et al., 2004), was used since research on DHA treatment is currently limited for
this murine model. In addition to typical markers of lung inflammation; such as
cytotoxicity, the occurrence of LMP, and lung histopathology, the shifts in macrophage
phenotype were also assessed.
Each chapter contributes to a better understanding of DHA as a potential treatment
for particle-induced inflammation. The aim of Chapter 3 was to assess the differences
between the responses of the macrophage phenotypes in regard to particle exposure and a
prophylactic DHA treatment in vitro. Chapter 3 also evaluated if the in vitro outcomes
translated to in vivo effects for an acute particle exposure model. In order to get a better
understanding on the effects of DHA treatment within the Balb/c murine model, Chapter 4
aimed to assess DHA as a potential prophylactic treatment for a semi-acute and a chronic
in vivo particle exposure model. Most research on DHA treatment is assessing it as a
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prophylaxis, but research of DHA as a possible therapeutic is scarce. In reality, treatment
to inflammatory diseases typically occurs after inflammation has ensued. Therefore,
Chapter 5 evaluated DHA as a potential therapeutic treatment after semi-acute and chronic
in vivo particle exposure models.
The overall hypothesis is that DHA downregulates the inflammatory response of
macrophages in response to particle-induced inflammation, but this response is not uniform
across the different macrophage phenotypes. The anti-inflammatory activity of DHA
occurs by a combination of altering LMP and shifting macrophage phenotype. In addition,
the effects of DHA will be more effective in treating MWCNT than SiO 2 in the Balb/c
murine exposure model.
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Chapter 2
Materials and Methods

2.1 in vitro experimental procedures
2.1.1 Particle Preparations
Preparations and characteristics of a highly inflammatory multi-walled carbon nanotube
[MWCNT; provided by the National Toxicology Program at NIEHS (Hamilton et al., 2012;
labeled as FA21)] and acid-washed crystalline SiO2 (SiO2; Min-U-Sil-5, Pennsylvania
Glass Sand Corp.; Pittsburgh, PA, USA) are as previously described (Hamilton et al., 2012,
p. 3; Thakur et al., 2009). Briefly, both particles were prepared fresh in PBS/7.5% bovine
serum albumin solution (A8412, Sigma-Aldrich; St. Louis, MO, USA). Particle
suspensions were sonicated (550 watts, 20 kHz, 1 minute, 35% amplitude) in a cup-horn
sonicator. Stock concentrations were 5 mg/mL and experimental concentrations were 50
µg/mL.

2.1.2 Isolation of Alveolar Macrophages
Both male and female wild type Balb/c mice were euthanized by a lethal dose of sodium
pentobarbital (150 mg/kg, EuthasolTM) by intraperitoneal injection; a method consistent
with the American Veterinary Medical Association guidelines. This method of euthanasia
causes minimal distress to the mice along with ensuring no injury to the lungs. Cells within
the lungs were isolated by performing whole lung lavages with ice-cold PBS as previously
described (Hamilton et al., 2012; Jessop & Holian, 2015). Briefly, the lungs were removed
from the body, lavaged, and pooled together to obtain optimal cell yields. Lung lavaged
9

cells were isolated by centrifugation (400 x g, 5 min, 4°C) and cell counts were obtained
via Coulter Z2 particle counter (Beckman Coulter; Brea, CA, USA). This process was
repeated several times to establish n=3 for in vitro experimental replicates.

2.1.3 Cell Culture and Polarization of Macrophage Phenotypes
Isolated alveolar macrophages were suspended in RPMI-1640 media (Corning; Corning,
NY, USA) supplemented with 10% fetal bovine serum (VWR; Radnor, PA, USA), 1%
penicillin-streptomycin (Corning) and 1% sodium pyruvate (Corning). Cells were
suspended at 1x105 cells/well with 100 µL/well for 96-well plate formats, 2x105 cells/well
with 400 µL/well for 24-well plate formats, and 5x105 cells/well with 3 mL/well for 6-well
plate formats. For macrophage phenotype polarization, lavaged cells were polarized into
the different phenotypes and incubated at 37°C in a 5% CO 2 incubator for 24-hours as
follows: M1 (20 ng/mL IFNγ [PeproTech; Rocky Hill, NJ, USA] + 10 pg/mL LPS) (Genin
et al., 2015), M2a (20 ng/mL IL-4 [PeproTech] + 20 ng/mL IL-13 [PeproTech]) (Genin et
al., 2015), M2b (immune complex; IC, consisting of 150 μg/mL anti-chicken egg albumin
antibody [Sigma-Aldrich] + 15 μg/mL chicken egg white albumin [Sigma-Aldrich]),
incubated at 37°C for 30 minutes to form IC, and then 50 ng/mL LPS was added) (Yue et
al., 2017), or M2c (20 ng/mL IL-10 [eBioscience; San Diego, CA, USA] + 20 ng/mL TGFβ [R&D Systems; Minneapolis, MN, USA]) (Zizzo, et al., 2012; Kim, et al., 2019).
Treatments for each experiment are described below.
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2.1.4 Cytotoxicity Assays
For macrophage phenotype cytotoxicity experiments, isolated alveolar macrophages were
polarized and plated in 96-well plates for 24-hours at 37°C (as described above). After 24hours the phenotype media was aspirated, cells were washed with PBS, and cells were
given RPMI media (described above) supplemented with either vehicle (control volume of
100% EtOH) or docosahexaenoic acid [DHA; 25 μM, Cayman Chemical; Ann Arbor, MI,
USA (Wierenga et al., 2019; Wiesenfeld et al., 2001)] for 48-hours at 37°C. Particles
(MWCNT or SiO2, 50 µg/mL) and LPS for priming (20 ng/mL) were added to the cells for
24-hours at 37°C. For EtOH vs BSA cytotoxicity experiments, isolated alveolar
macrophages were plated in a 96-well plate format and supplemented with either vehicle
(control volume of 100% EtOH or BSA) or DHA (25 μM, Cayman Chemical) for 48-hours
at 37°C. DHA was either suspended with 100% EtOH or conjugated with BSA [provided
by Dr. Pestka at Michigan State University; East Lansing, MI, USA (Wierenga et al.,
2019)]. Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the
cells for 24-hours at 37°C. Cell damage was determined by various cellular cytotoxicity
assays (CytoTox 96 cytotoxicity assay or CellTiter96 ® AQueous one solution cell
proliferation assay, Promega; Madison, WI, USA) and IL-1β release (mouse IL-1β DuoSet
ELISA, R&D Systems) according to manufacturer’s protocols.

2.1.5 Particle Uptake & Flow Cytometry
Isolated alveolar macrophages were polarized and plated in 6-well plates for 24-hours at
37°C (as described above). After 24-hours the phenotype media was aspirated, cells were
washed with PBS, and cells were given RPMI media (described above) supplemented with
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either vehicle (control volume of 100% EtOH) or DHA (25 μM) for 24-hours at 37°C.
Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the cells for 4hours at 37°C. Particle uptake was determined by flow cytometry on the Attune ® NxT
Acoustic Focusing Cytometer (Life Technologies; Carlsbad, CA, USA) in the Flow
Cytometry Core at the University of Montana by using changes in side scatter (SSC) and
anti-mouse antibody F4/80-PE/Cy7 (clone BM8, Biolegend; San Diego, CA, USA) to
identify alveolar macrophages. Data analysis was performed in FlowJo 10.6 (BD; Franklin
Lakes, NJ, USA).

2.1.6 Phagolysosomal Membrane Permeability (LMP) Assay
Isolated alveolar macrophages were polarized and plated in 24-well plates for 24-hours at
37°C (as described above). After 24-hours the phenotype media was aspirated, cells were
washed with PBS, and cells were given RPMI media (described above) supplemented with
either vehicle (control volume of 100% EtOH) or DHA (25 μM) for 24-hours at 37°C.
Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the cells for 4hours at 37°C. LMP was assessed using methods modified from Aits et al. (Aits et al.,
2015) as previously described (Jessop et al., 2017). Briefly, cells were washed twice with
PBS and incubated with 200 µL cytosol extraction buffer (250 mM sucrose, 20 mM Hepes,
10 mM KCl, 1.5 mM MgCL2, 1 mM EDTA, 1 mM EGTA, 0.5 mM pefabloc, + digitonin)
on ice for 15 minutes while rocking. The digitonin concentrations for optimal cytosolic
fraction extraction was obtained previously via titrations of Balb/c alveolar macrophages
(M0 = 12.5 µg/mL, M1 & M2a = 17 µg/mL, M2b = 25 µg/mL, and M2c = 22.5 µg/mL).
β-N-acetylglucosaminidase (NAG) activity was measured by adding 30 µL cytosolic
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extract to 100 µL of NAG buffer (0.2 M sodium citrate and 300 µg/mL 4methylumbelliferyl-2-acetamido-2-deoxy-β-D-glucopyranoside) and read on a plate reader
(20 minutes, 45 second intervals, 356 nm excitation, 444 nm emission). Lactate
dehydrogenase (LDH) activity was measured according to the manufacturer’s protocol
(CytoTox 96 cytotoxicity assay, Promega) and used as an internal control to which NAG
activity was normalized.

2.2 in vivo experimental procedures
2.2.1 Particle Preparations
Preparations and characteristics of MWCNT and SiO2 particles are the same as described
above. Briefly, both particles were prepared fresh in dispersion media vehicle (DM; 0.6
mg/mL mouse serum albumin [Sigma-Aldrich] and 0.01 mg/mL 1,2-dipalmitoyl-snglycero-3-phosphocholine [Sigma-Aldrich] in PBS). The particle suspensions were
sonicated (550 watts, 20 kHz, 5 minutes, 35% amplitude) in a cup-horn sonicator.

2.2.2 Mice and Diets
Both male and female wild type Balb/c mice, 6-8 weeks old, were used in equal numbers.
The number of mice used for each experiment are depicted within each figure legend. The
mice were maintained in microisolation containers within the BSL-2 Laboratory Animal
Resources facility at the University of Montana in the accordance with the Guide for the
Care and Use of Laboratory Animals. The animal room is programmed on a 12-hour
light/dark cycle at approximately 18-26C with food and water provided ad libitum. The
animals were monitored on a daily basis and weighed once a week. The animal care facility
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at the University of Montana is staffed with full-time veterinarians that are AAALAC
accredited. The animal use protocols were in accordance with the University of Montana
Institutional Animal Care and Use Committee. Please note that sex comparisons were not
performed due to too low of numbers for each sex separately; therefore, males and females
were pooled together within each group for analysis.
Formulations of experimental diets are summarized in Table 1. Briefly, modified
American Institute of Nutrition (AIN)-93G powdered diet (Dyets, Inc.; Bethlehem, PA,
USA) containing 70 g/kg fat was prepared with 10 g/kg food-grade corn oil (Wesson Pure
100% Natural Corn Oil, Amazon; Seattle, WA, USA) to provide essential fatty acids. The
control diet contained 60 g/kg food-grade oleic safflower oil (Oleico Natural Safflower Oil,
Walmart; Bentonville, AR, USA). The oleic safflower oil was replaced with 25 g/kg
microalgal oil containing 40% DHA (DHASCOTM, Martek Biosciences Corp., provided
by Dr. Pestka at Michigan State University; East Lansing, MI) which corresponded to 1%
(w/w) DHA. This dosage was chosen to represent a relevant human dietary intake of 5
g/day and was conducted in collaboration with Dr. Pestka in a similar manner as previously
described (Bates et al., 2016). The European Food Safety Authority deemed supplements
containing 5 g/day omega-3 polyunsaturated fatty acids from microalgal oil safe for human
consumption (EFSA NDA Panel, 2014). All diets were changed every 48-hours to prevent
oxidation. Confirmation of fatty acid composition within red blood cells was sent for
analysis [Dr. Pestka’s laboratory at Michigan State University (prophylactic semi-acute
study in Chapter 4 only), East Lansing, MI, USA; or OmegaQuant (all other mouse
studies); Sioux Falls, SD, USA] which are described within each chapter separately.
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Table 1. Formulations of experimental diets.
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2.2.3 Experimental Designs
The overall study designs are described and graphically depicted within each chapter
separately. For each mouse study, Balb/c mice were fed either a control or 1% DHAcontaining diet (25 g/kg). Prior to each particle instillation the mice were anesthetized with
isoflurane (5%, inhaled) so as not to use any restraints or cause distress and then
oropharyngeal instilled with either DM-only vehicle (50 µl/mouse), MWCNT (50
µg/mouse), or SiO2 (1 mg/mouse). The mice were euthanized by a lethal dose of sodium
pentobarbital (150 mg/kg, EuthasolTM) by intraperitoneal injection; a method consistent
with the American Veterinary Medical Association guidelines. This method of euthanasia
causes minimal distress to the mice along with ensuring no injury to the lungs.

2.2.4 Isolation of Pulmonary Cells
Cells within the lungs were isolated by performing lung lavages and assessed as previously
described (Burmeister et al., 2019; Jessop & Holian, 2015). Briefly, the lungs were
removed from the body and lavaged with ice-cold PBS to obtain optimal cell yields. The
first pull (instillation of 0.5 mL of ice-cold PBS, withdrawn, then the same fluid repeated
twice more) consisted of the most concentrated lung lavage fluid (LLF). Lung lavaged cells
were isolated by centrifugation (400 x g, 5 min, 4°C) and cell counts were obtained via
Coulter Z2 particle counter (Beckman Coulter; Brea, CA, USA). Cells were stained for
differential analysis via Wright-Geimsa stain in a Hematek 2000 autostainer (Miles-BayerSiemens Diagnostics; Deerfield, IL, USA). Alveolar macrophages (AM) within the LLF
were isolated and cultured ex vivo in RPMI-1640 media (Corning; Corning, NY, USA)
supplemented with 10% heat-inactivated fetal bovine serum (VWR; Radnor, PA, USA),
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1% penicillin-streptomycin (Corning) and 1% sodium pyruvate (Corning) for 24-hours at
37°C with LPS for priming (20 ng/mL) to assess IL-1β levels within the supernatant.

2.2.5 Analysis of Cell Damage and Inflammatory Mediators
Cell damage and inflammatory markers were assessed within LLF of the mice. Cell
damage was determined by release of LDH (CytoTox 96 cytotoxicity assay, Promega) and
protein concentration (Pierce BCA protein assay, Thermo Fisher Scientific; Waltham, MA,
USA) according to manufacturer’s instructions. Inflammatory cytokines were assessed by
using a customized MesoScale Discovery U-PLEX assay platform (IFNγ, IL-1β, TNFα,
IL-33, IL-6, IL-10, IL-13; Meso Scale Diagnostics LLC; Rockville, MD, USA) according
to manufacturer’s instructions. LMP was determined by total cathepsin (Z-LR-AMC
fluorogenic peptide substrate, R&D Systems) and cathepsin B release (cathepsin B
inhibitor II - Calbiochem, Millipore Sigma; Burlington, MA, USA) within the LLF and IL1β release (mouse IL-1β DuoSet ELISA, R&D Systems) within the supernatants of isolated
ex vivo AM.

2.2.6 Macrophage Phenotype Analysis
Macrophage phenotype was assessed within lung and spleen tissues. Sections of the tissues
were snap-frozen on the day of harvest and RNA was isolated (TRIzol®, Thermo Fisher
Scientific) according to manufacturer’s instructions. All RNA was converted to cDNA
(iScript RT Supermix, Bio-Rad; Hercules, CA, USA) and qPCR analysis was performed
(SsoAdvanced Univ. SYBR Green Supermix, Bio-Rad) according to manufacturer’s
instructions to determine macrophage phenotype: M1 [CXCL10, IL-1β, TNFα, iNos (Dong
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& Ma, 2018; Genin et al., 2015; Hesketh et al., 2017; Jiang & Zhu, 2016; Labonte et al.,
2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)], M2a [FN1, CD206,
Fizz1, YM1 (Dong & Ma, 2018; Genin et al., 2015; Hesketh et al., 2017; Jiang & Zhu,
2016; Labonte et al., 2014; Tomioka, 2016)], M2b [CCL1, LIGHT, CXCL3, SPHK1
(Edwards et al., 2006; He et al., 2013; Hesketh et al., 2017; Jiang & Zhu, 2016; Labonte et
al., 2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)], and M2c [CD163,
CXCL13, TIMP1, TLR8 (Hesketh et al., 2017; Jiang & Zhu, 2016; Koscsó et al., 2013;
Labonte et al., 2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)]. All
qPCR primers with associated positive controls and reference genes used were validated
PrimePCR SYBR Green assays from Bio-Rad. All signals were collected via 384-well
CFX Maestro (Bio-Rad, supplied by Dr. Patel at FYR Diagnostics, Missoula, MT and Dr.
Kreitinger at Dermaxon, Missoula, MT, USA) and levels were normalized to reference
gene β-2 microglobulin (B2m; ΔCq). Relative gene expressions of MWCNT and SiO 2 of
control-fed mice were normalized to DM-only of control-fed mice (ΔΔCq) to assess particle
effect. The relative gene expressions of DM-only, MWCNT, and SiO2 of the 1% DHA-fed
mice were normalized to DM-only, MWCNT, and SiO2 of the control-fed mice;
respectively, (ΔΔCq) to assess diet effect. The ΔΔCq values were analyzed within a heatmap. A dominant phenotype shift was indicated by an upregulation of gene expression of
at least three of the four genes within each phenotype or a trending increase indicated by
upregulation of two of the four genes.
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2.2.7 Histopathology
Lungs from each mouse were inflation-fixed through the trachea with 3%
paraformaldehyde-PBS and placed in this same fixative overnight at 4°C. The lungs were
washed with ice-cold PBS, dehydrated with 70% EtOH, and paraffin-embedded. Tissue
sections (5 µm) were stained with either Gömöri (prophylactic semi-acute study in Chapter
4 only) or Masson’s (all other mouse studies) trichrome for histological analysis. Mouse
lung sections were imaged at 10x using Nikon E 800 epi-fluorescent/transmitted light
microscope with Olympus DP71 camera and CellSens software in the Molecular Histology
and Fluorescence Imaging Core at the University of Montana.
The lung tissues were scored in a blinded fashion by either a board-certified
veterinary pathologist (Dr. Jack Harkema, Michigan State University; prophylactic semiacute study in Chapter 4 only) or two observers separately (all other mouse studies) with
three mice per treatment group. The degree of lung disease visible within the lung sections
were scored using a 5-point scale system (0, 1, 2, 3, 4) for the percentage of total pulmonary
tissue effected with (0) being no effect, (1) minimal (<10 %), (2) slight (10 – 25 %), (3)
moderate (26 – 50 %), and (4) severe (51 – 75 %) lung pathology by assessing collagen
deposition, extracellularity, inflammation, lesion formation, particle encapsulation, and
airway thickening. For the mouse studies where two observers scored the pathology
separately, Cronbach’s-α was used to assess reliability between scorers where inter-rater
reliability was significant at 0.956 indicating agreement between the scores of the two
observers. The values shown are the median of the two scorers’ values. Lung airway
thickness was measured on the iCys Laser Scanning Cytometer (ThorLabs; Newton, NJ,
USA) in the Fluorescence Cytometry Core at the University of Montana. Six airways with
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four measurements per airway in duplicate lung sections per mouse were measured with
three mice per treatment group.

2.3 Statistical Analysis
Depending on the data type, data had to undergo a log-transformation in order to equalize
the variance, followed by a parametric one- or two-way analysis of variance (ANOVA)
and post hoc mean comparison (Holm-Sidak). Data was expressed as mean ± SEM with
0.05 significance level. Subjective histopathology scoring is ordinal level data; therefore,
raw scores were rank-transformed prior to ANOVA and post hoc analysis. Graphics and
analyses were performed on PRISM 8.3.1 (GraphPad; San Diego, CA, USA).
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Chapter 3
DHA impacts macrophage phenotype and LMP with particle
exposure in vitro and an acute particle exposure in vivo

3.1 Abstract
Inhalation of certain particles can cause acute and chronic pulmonary inflammation;
however, treatments are currently lacking within this field. Docosahexaenoic acid (DHA)
is an omega-3 polyunsaturated fatty acid that has been reported to have various antiinflammatory capabilities. Since the anti-inflammatory mechanisms of DHA are unclear
for particle-induced inflammation, this study tested the hypothesis that DHA
downregulates the inflammatory response of macrophages in response to particles by a
combination of altering phagolysosomal membrane permeability (LMP) and shifting
macrophage phenotype. Balb/c primary alveolar macrophages (AM) were isolated and
polarized into M1, M2a, M2b, or M2c macrophage phenotypes in vitro, treated with DHA,
and exposed to either a multi-walled carbon nanotube or crystalline silica to assess
cytotoxicity, particle uptake, and LMP. Results demonstrated that DHA could be proinflammatory or anti-inflammatory depending on the particle exposure. There were
minimal effects for cytotoxicity, a more robust effect for particle uptake with silica, and
differences in LMP between the phenotypes. However, DHA appeared to beneficially
impact the M2c phenotype with particle exposure the most. To determine if DHA affected
particle-induced inflammation in a similar manner in vivo, Balb/c mice were placed on a
control or 1% DHA diet for 3 weeks, instilled with the same particles, and euthanized 24hours after particle exposure. Results indicated that in contrast to the in vitro studies, DHA
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increased pulmonary inflammation, increased LMP, and shifted macrophage phenotype
when exposed to particles. These findings suggest that DHA may have had an increased
effect on other pulmonary cells at this acute timepoint rather than AM, which could account
for the increased inflammatory response.

3.2 Introduction
Exposure to airborne particles can cause acute and chronic inflammation in the lungs which
can lead to serious inflammatory diseases, such as lung fibrosis, and contribute to
autoimmune diseases. Understanding the mechanisms of lung inflammation and
development of preventative and therapeutic treatments are lacking in this field (Wong et
al., 2016). One possible treatment that has been shown to have anti-inflammatory effects
is an omega-3 polyunsaturated fatty acid; docosahexaenoic acid (DHA) (Serhan et al.,
2008), which is found in fish oil. It has been reported that there has been a 60% increase
between 2007 and 2012 in the dietary intake of fish oil supplementation; however, it’s antiinflammatory mechanisms are not fully understood (Clarke et al., 2015). Current research
using DHA as a potential treatment for particle-induced inflammation is scarce, but there
is evidence that shows omega-3 polyunsaturated fatty acids can suppress particle-induced
pulmonary and systemic inflammation (X.-Y. Li et al., 2017; Bates et al., 2016).
Alveolar macrophages regulate the immune response to various inhaled foreign
particles (such as multi-walled carbon nanotubes; MWCNT, and crystalline silica; SiO2).
Macrophages phagocytose these foreign particles and attempt to process them for
elimination in order to maintain both homeostasis and a sterile environment within the
lung. Macrophages can’t degrade these particles and their persistence in the lung can lead
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to inflammation that can progress to fibrosis and systemic diseases (Byrne et al., 2015).
Inflammation induced by macrophages is initiated by activation of two signals: 1)
activation of the NF-B pathway and 2) assembly of the NLRP3 inflammasome (Schroder
& Tschopp, 2010). The NF-B pathway is responsible for the formation of pro-IL-1 and
components of the NLRP3 inflammasome (Lamkanfi & Dixit, 2014; Martínez-Micaelo et
al., 2016; Schroder & Tschopp, 2010). Before activation of signal 2 occurs, there is a
cascade of events that happen: environmental stimuli (such as phagocytosed particles)
induce phagolysosomal membrane permeability (LMP) causing the release of various
proteases into the cytosol, one being cathepsin B. Cathepsin B has been reported to activate
the NLRP3 inflammasome which in turn cleaves pro-caspase-1 into active caspase-1
causing pro-IL-1 processing into its mature form of IL-1 for secretion (Lamkanfi &
Dixit, 2014; Martínez-Micaelo et al., 2016; Schroder & Tschopp, 2010; Strowig et al.,
2012).
However, macrophages are phenotypically complex and subject to their
environment, such that their functions and contribution to inflammation are dependent
upon various signaling factors. These stimuli will determine what macrophage phenotype
is present under any given situation, which regulates the overall macrophage response to
foreign particles. There is always a mixture of macrophage phenotypes present; however,
the overall response is expected to be based upon the dominant phenotype. There are two
main phenotypes of macrophages that are broadly defined as the classically activated, “proinflammatory” M1 and the alternatively activated, “anti-inflammatory” M2. The M2
phenotype also has additional subsets of M2a, M2b, M2c, and M2d/tumor-associated
macrophages (Byrne et al., 2015; Italiani & Boraschi, 2014; Labonte et al., 2014). The
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regulation of the M1 and M2 macrophage phenotype balance is crucial to understand the
outcome of particle-induced inflammation. Depending on the overall environment present
during particle exposure, macrophages could either be aiding in inflammation or
suppressing inflammation through phenotype shifts. The actual contributions of M1 and
M2 macrophages in disease progression are not fully established and likely depend on
specific diseases. Furthermore, the mechanisms of the formation of the various M2 subsets,
especially M2b and M2c, are not well-defined in regard to particle-induced inflammation.
The hypothesis in this chapter is that DHA downregulates the inflammatory
response of macrophages in response to particle-induced inflammation, but that the
response is not uniform across the different macrophage phenotypes. The antiinflammatory activity of DHA occurs by a combination of altering LMP and shifting
macrophage phenotype. To test this hypothesis, in vitro studies were conducted using
freshly isolated alveolar macrophages from Balb/c mice that were polarized into the
different phenotype subsets and evaluated for responses to MWCNT and SiO 2 in the
presence or absence of DHA. Additional in vivo studies were conducted using Balb/c mice
that were fed a prophylactic 1% DHA diet compared to a control diet, instilled with these
same particles, and examined for in vivo inflammation and phenotypic changes.

3.3 Results
3.3.1 Cytotoxicity assessments of DHA in vitro
Understanding the contributions of the individual M1 and M2 macrophage phenotypes is
crucial to assessing the inflammatory effects of particles since macrophages are an essential
cell that regulates the innate immune response to inhaled foreign particles. The impacts on
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the various M2 subsets, especially M2b and M2c, are not well-defined in regard to particleinduced inflammation. Therefore, the effects of particle exposure and DHA treatment was
assessed in order to determine the response differences between each macrophage
phenotype. A number of techniques have been used to add DHA to cells in vitro which is
most often either bound with BSA or suspended with EtOH and also varies between cell
type (Martínez-Micaelo et al., 2016; Wiesenfeld et al., 2001; Williams-Bey et al., 2014).
Therefore, initial studies were conducted to assess the effects of DHA on particle exposure
to compare EtOH and BSA vehicles using Balb/c alveolar macrophages (AM). The results
showed that when AM were exposed to MWCNT, the treatment groups had similar cell
viability (Figure 1A); however, there was a significant decrease in IL-1β release from these
same cells when comparing DHA-EtOH to both EtOH-only and DHA-BSA treatments
(Figure 1B). There was a significant improvement in cell viability with AM treated with
DHA-EtOH when exposed to SiO2 compared to EtOH-only and DHA-BSA as shown in
Figure 1A. This was further supported by a significant decrease in IL-1β release of these
treatment groups from these same cells (Figure 1B). Therefore, initial studies concluded
that the use of EtOH instead of BSA in vitro for the DHA vehicle with Balb/c AM resulted
in the least toxicity. Literature findings supported these results in other cell types and
confirmed that an in vitro DHA concentration of 25 μM should be used which is within the
physiological range (Wiesenfeld et al., 2001).
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Figure 1. Comparing BSA and EtOH as DHA vehicle in vitro. Balb/c AM supplemented
with vehicle (EtOH or BSA) or DHA (25 μM) for 48 hours and exposed to particle
(MWCNT or SiO2, 50 μg/mL) for 24 hours. (A) Cell viability comparing treatment groups.
(B) IL-1β release from those same cells. Data presented as mean ± SEM, n=3. *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001 compared to baseline, + compared to different
treatments within the same exposure group. Some analyses were done with logtransformed data. AMs, Balb/c alveolar macrophages; EtOH, ethanol; BSA, bovine serum
albumin; DHA, docosahexaenoic acid; MWCNT, multi-walled carbon nanotube; SiO2,
crystalline silica.
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In order to assess the cytotoxic effects of particles on each polarized macrophage
phenotype, AM were treated with DHA for 48 hours, exposed to particles for 24-hours and
lactate dehydrogenase (LDH) release was evaluated to determine cell death. Media-only
controls were included throughout the in vitro studies as a confirmation that EtOH was not
having a toxic effect on AM and EtOH controls were included to demonstrate that the
reactions were caused by DHA specifically and not due to EtOH exposure. Results
indicated that there was a trending decrease of cell death for unpolarized AM (M0) treated
with DHA and exposed to SiO2 when compared to the media-only control (Figure 2A);
however, there was no difference for MWCNT with DHA treatment. DHA didn’t appear
to have a cytotoxic effect compared to the media-only control in the M1 phenotype for
either particle compared to the media-only controls (Figure 2B); however, the M2 subsets
responded differently. In M2a AM, there was a trending increase in cell death when DHA
was present and exposed to SiO2, but there was no difference with MWCNT exposure
compared to media-only controls (Figure 2C). For M2b, there were significant decreases
in cell death with DHA treatment regardless of particle exposure (Figure 2D). There was
no difference in cell death when exposed to MWCNT, but there was a trending decrease in
cell death when exposed to SiO2 with DHA treatment for M2c (Figure 2E). The beneficial
effects of DHA treatment with particle exposure appeared to be M2b>M2c>M1>M2a. The
cytotoxicity assessment supported the hypothesis that cytotoxic responses induced by
particles with DHA treatment differ between the macrophage phenotypes.
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Figure 2. Lactate dehydrogenase (LDH) analysis of macrophage phenotypes in vitro.
Balb/c AM were either (A) not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b,
or (E) M2c macrophage phenotypes for 24 hours, supplemented with vehicle (100% EtOH)
or DHA for 48 hours, and exposed to particles (MWCNT or SiO 2) and LPS priming for 24
hours. LDH levels were assessed in AM supernatant. Data presented as mean ± SEM, n=3.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle control, + compared
to different treatments within the same exposure group. Analyses were done with logtransformed data.
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3.3.2 Effects of DHA on IL-1β release in vitro
Particles are engulfed in a phagolysosome after AM phagocytosis that can result in particleinduced phagolysosomal membrane permeabilization (LMP) which leads to the release of
IL-1β and cytotoxicity. Little is known about IL-1β release between the macrophage
phenotypes or the ability of DHA to block this release in regard to particle exposures.
Furthermore, this information can be used to help determine if the particle cytotoxicity, as
shown above, is linked to LMP and if the macrophage phenotypes process particles
differently. Therefore, IL-1β release after 24-hours of particle exposure using the same AM
supernatant of the cells described above in the cytotoxicity assay was measured. As
expected, there was no IL-1β release from any of the AM phenotypes for the no particle
media-only groups (Figure 3). However, exposure to MWCNT and SiO 2 without DHA
treatment induced varied levels of IL-1β release between the phenotypes which ranked
M2c>M2b>M2a>M1 (Figure 3).
Upon treatment with DHA, M0 AM had a significant decrease of IL-1β release
when exposed to MWCNT and a decreasing trend when exposed to SiO 2 when compared
to media-only controls (Figure 3A). In M1 AM, there was a trending decrease in IL-1β
release when exposed to MWCNT and treated with DHA compared to the media-only
control; however, there was no change in IL-1β levels compared to media-only control
when exposed to SiO2 (Figure 3B). There appeared to be a slight increase of IL-1β release
compared to media-only control when treated with DHA and exposed to SiO2, but no
difference with MWCNT for M2a AM (Figure 3C). Both M2b (Figure 3D) and M2c
(Figure 3E) AM had a significant or trending decrease in IL-1β release when treated with
DHA and exposed to either particle compared to media-only controls. The M2c results
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Figure 3. IL-1β release of macrophage phenotypes in vitro. Balb/c AM were either (A) not
polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 48 hours,
and exposed to particles (MWCNT or SiO2) and LPS priming for 24 hours. IL-1β levels
were assessed in AM supernatant. Data presented as mean ± SEM, n=3. *P<0.05, **P<0.01,
***P<0.001, ****P<0.0001 compared to no particle control, + compared to different
treatments within the same exposure group. Analyses were done with log-transformed data.

30

positively correlated to the decreased cell death with DHA treatment as shown earlier. The
ability of DHA to significantly decrease IL-1β levels upon particle exposure ranked as
M2c>M2b>M1>M2a. These results indicated that the macrophage phenotypes are
responding differently to particles. The prophylactic treatment of DHA with two different
types of particle exposures had a positive effect on cell viability and IL-1β release which
supports the hypothesis that DHA is protective over particle-induced inflammatory
responses which varies between each macrophage phenotype. In addition, these novel
findings point out that there are significant differences between the various macrophage
phenotypes which indicates that they should not be grouped together for interpretation;
especially the M2c subset in this particular model.

3.3.3 Effect of DHA on particle uptake and LMP in vitro
There were differences between the macrophage phenotypes upon DHA treatment in
regard to cell viability which could be attributed to the differences in IL-1β release. IL-1β
release is linked to LMP which can occur after AM phagocytose particles. Therefore, these
differences between the responses of the macrophage phenotypes could be attributed to
different rates of particle phagocytosis which has not been previously investigated. Particle
uptake by AM was measured with and without DHA treatment and 4-hours of particle
exposure by assessing changes in side scatter. The M0 AM were the most efficient in
particle uptake; especially with SiO2, and the M1 AM were the least (Figure 4 A,B). This
could explain the relative particle toxicity and lowest IL-1β release in the M1 population.
There was a significant increase in particle uptake by M0 AM with DHA treatment
regardless of particle exposure when compared to media-only controls

31

Figure 4. Particle uptake of macrophage phenotypes in vitro. Balb/c AM were either (A)
not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 24 hours,
and exposed to particles (MWCNT or SiO2) and LPS priming for 4 hours. Particle uptake
was determined by side scatter via flow cytometry. Data presented as mean ± SEM, n=3.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle control, + compared
to different treatments within the same exposure group. Analyses were done with logtransformed data.
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(Figure 4A). There was a significant decrease in particle uptake with DHA treatment for
M1 AM when exposed to SiO2, but no change when exposed to MWCNT (Figure 4B).
M2a AM (Figure 4C) were similar to M0 AM where they had a significant increase of
particle uptake with DHA treatment regardless of particle exposure. M2b (Figure 4D) and
M2c (Figure 4E) AM were similar where they had opposite particle reactions when treated
with DHA: there was a decrease of particle uptake with MWCNT and a significant increase
with SiO2 for both phenotypes compared to media-only controls.
Once the particles are phagocytosed by AM they are enclosed in a phagolysosome
where foreign material is intended to be degraded in order to maintain homeostasis.
However, non-degradable particles can cause LMP which leads to NLRP3 inflammasome
formation and activation of the inflammatory pathway cascade. Since the macrophage
phenotypes showed differences in particle uptake, alterations in the stability of the
phagolysosomal membrane was assessed after 4-hours of particle exposure. LMP was
determined by β-N-acetylglucosaminidase (NAG) activity; a lysosomal-specific enzyme,
in the cytosolic fraction of AM polarized into the various phenotypes. Results showed that
MWCNT exposure caused a significant particle-induced increase of LMP only in the M2c
AM which is consistent with this phenotype’s largest release of IL-1β. However, upon
DHA treatment both the M2c (Figure 5E) and M0 (Figure 5A) AM had trending decreases
in NAG release for MWCNT exposures and a significant decrease in NAG release with
DHA treatment for SiO2 exposures when compared to media-only controls. This indicates
less LMP which correlates to increased phagolysosomal membrane stability. In contrast,
M1 (Figure 5B) and M2a (Figure 5C) AM had an increase in NAG release upon DHA
treatment compared to media-only controls for both particle
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Figure 5. LMP analysis of macrophage phenotypes in vitro. Balb/c AM were either (A)
not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 24 hours,
and exposed to particles (MWCNT or SiO2) and LPS priming for 4 hours. NAG release
was assessed in the AM cytosolic fraction and normalized to LDH levels. Data presented
as mean ± SEM, n=3. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle
control, + compared to different treatments within the same exposure group. Some analyses
were done with log-transformed data.
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exposures; indicating an increase in LMP which correlates to a decrease in phagolysosomal
membrane stability. The M2b AM remained unchanged by DHA treatment compared to
the media-only control for either particle (Figure 5D). These results demonstrate that DHA
stabilized the phagolysosomal membrane of the M0 and M2c AM after particle exposure.
The benefits of DHA treatment for particle-induced LMP ranked M2c>M2b>M2a>M1 for
the AM phenotypes. Taken together for the in vitro studies, DHA effected how
macrophages uptake particles and altered the phagolysosomal membrane; both which
differ among the macrophage phenotypes. In particular, upon DHA treatment the M2c
phenotype stabilized the phagolysosomal membrane and decreased cytotoxicity regardless
of increased particle uptake. As opposed to the M2a phenotype where DHA also increased
particle uptake, but resulted in increased LMP and increased cytotoxicity. This supports
the hypothesis that particle-induced inflammatory responses were not uniform across the
different macrophage phenotypes; however, DHA did not always downregulate the
inflammatory responses.

3.3.4 Effect of DHA on lung injury and inflammation in vivo
The in vitro studies demonstrated that DHA altered the response of AM which was
dependent upon macrophage phenotype. In order to determine whether the in vitro
outcomes translated to in vivo effects, mice were put on a prophylactic 1% DHA diet and
instilled with an acute particle exposure. The overall study design is depicted in Figure 6.
Briefly, Balb/c mice were put on either a control or 1% DHA diet for three weeks. Twentyfour hours prior to evaluation, the mice were oropharyngeal instilled with either dispersion
media-only vehicle (DM; 50 µl/mouse), MWCNT (50 µg/mouse), or SiO2
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Figure 6. Experimental design of prophylactic acute model. Balb/c mice; 6-8 weeks old,
were put on a control or 1% DHA diet for 3 weeks. 24 hours prior to evaluation, the mice
weigh weekly
were oropharyngeal instilled with DM-only, MWCNT,
or SiO2. DM; dispersion media,
MWCNT; multi-walled carbon nanotube, SiO2; crystalline silica.
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18

P24h (OmegaQuant):
Experimental Groups

Fatty Acid
14:0
16:0
16:1 (ω-7) trans
16:1 (ω-7)
18:0
18:1 trans
18:1 (ω-9)
18:2 (ω-6) trans
18:2 (ω-6)
18:3 (ω-6)
18:3 (ω-3)
20:0
20:1 (ω-9)
20:2 (ω-6)
20:3 (ω-6)
20:4 (ω-6)
20:5 (ω-3)
22:0
22:4 (ω-6)
22:5 (ω-6)
22:5 (ω-3)
22:6 (ω-3)
24:0
24:1 (ω-9)

DM

Control Diet
MWCNT

0.15 ± 8.13E-05
27.61 ± 4.78E-03
0.06 ± 7.12E-05
0.35 ± 5.49E-04
12.91 ± 4.02E-03
0.18 ± 1.40E-04
19.02 ± 3.31E-03
0.19 ± 2.68E-04
8.25 ± 4.37E-03
0.07 ± 3.75E-05
0.07 ± 8.57E-05
0.18 ± 3.28E-04
0.53 ± 2.00E-04
0.22 ± 1.14E-04
1.24 ± 7.94E-04
19.11 ± 5.52E-03
0.06 ± 9.72E-05
0.14 ± 7.83E-05
2.38 ± 9.58E-04
2.34 ± 1.24E-03
0.30 ± 2.98E-04
4.26 ± 1.10E-03
0.18 ± 7.74E-05
0.20 ± 1.81E-04

0.15 ± 9.91E-05
27.40 ± 5.62E-03
0.06 ± 4.17E-05
0.35 ± 4.08E-04
13.72 ± 4.49E-03
0.12 ± 3.07E-05
18.65 ± 3.02E-03
0.15 ± 1.18E-04
7.97 ± 9.14E-04
0.07 ± 5.92E-05
0.07 ± 7.14E-05
0.14 ± 2.67E-04
0.47 ± 3.28E-04
0.19 ± 1.11E-04
1.07 ± 7.84E-04
19.49 ± 5.84E-03
0.05 ± 3.83E-05
0.13 ± 7.91E-05
2.18 ± 2.76E-04
2.32 ± 8.03E-04
0.23 ± 3.39E-04
4.67 ± 1.01E-03
0.17 ± 9.00E-05
0.18 ± 1.59E-04

SiO2
DM
% of fatty acid in RBC
0.13 ± 3.59E-05
0.24 ± 3.85E-05
27.70 ± 2.25E-03
31.35 ± 3.94E-03
0.07 ± 6.38E-05
0.05 ± 1.01E-04
0.36 ± 5.19E-04
0.44 ± 4.13E-04
13.03 ± 4.02E-03
11.11 ± 4.39E-03
0.17 ± 2.58E-04
0.13 ± 6.72E-05
18.28 ± 2.66E-03
16.87 ± 3.01E-03
0.15 ± 7.46E-05
0.12 ± 8.25E-05
7.78 ± 4.88E-03
9.33 ± 7.95E-03
0.06 ± 2.99E-05
0.03 ± 4.91E-05
0.06 ± 4.36E-05
0.07 ± 7.53E-05
0.16 ± 2.19E-04
0.17 ± 4.01E-04
0.47 ± 2.23E-04
0.33 ± 1.34E-04
0.20 ± 6.24E-05
0.16 ± 6.73E-05
1.18 ± 7.71E-04
0.97 ± 6.77E-04
19.52 ± 5.02E-03
7.83 ± 5.41E-03
0.06 ± 6.77E-05
1.69 ± 2.37E-03
0.14 ± 8.77E-05
0.16 ± 1.25E-04
2.29 ± 8.14E-04
0.80 ± 6.29E-04
2.56 ± 6.78E-04
0.43 ± 2.19E-04
0.27 ± 3.17E-04
0.55 ± 2.58E-04
4.98 ± 2.55E-03
16.77 ± 6.14E-03
0.19 ± 2.05E-04
0.21 ± 1.67E-04
0.20 ± 1.33E-04
0.19 ± 5.82E-05

1% DHA Diet
MWCNT

SiO2

0.21 ± 1.17E-04
30.12 ± 2.01E-03
0.05 ± 5.19E-05
0.36 ± 2.89E-04
11.97 ± 3.24E-03
0.13 ± 1.24E-04
16.59 ± 7.36E-04
0.14 ± 3.09E-04
9.67 ± 4.57E-03
0.04 ± 1.97E-05
0.07 ± 5.54E-05
0.14 ± 3.75E-04
0.32 ± 1.92E-04
0.17 ± 4.31E-05
1.12 ± 1.29E-03
8.52 ± 6.97E-03
1.64 ± 9.74E-04
0.16 ± 1.12E-04
0.80 ± 4.56E-04
0.42 ± 6.70E-04
0.51 ± 1.48E-04
16.42 ± 3.52E-03
0.22 ± 1.20E-04
0.21 ± 1.20E-04

0.23 ± 5.00E-05
31.17 ± 4.81E-03
0.08 ± 1.45E-04
0.41 ± 1.57E-04
11.45 ± 4.78E-03
0.14 ± 1.78E-04
16.61 ± 9.92E-04
0.15 ± 2.52E-04
8.74 ± 1.66E-03
0.05 ± 6.21E-05
0.08 ± 7.10E-05
0.18 ± 3.70E-04
0.36 ± 3.16E-04
0.16 ± 9.33E-05
1.00 ± 1.13E-03
8.24 ± 7.35E-04
1.63 ± 1.28E-03
0.16 ± 1.40E-04
0.90 ± 5.53E-04
0.46 ± 5.56E-04
0.59 ± 1.56E-04
16.82 ± 3.20E-03
0.22 ± 1.75E-04
0.19 ± 1.29E-04

Table 2. Fatty acid composition of red blood cells in prophylactic acute model. Data
presented in a percentage as mean ± SEM, n=4.
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Figure 7. Fatty acid analysis within red blood cells in prophylactic acute model. Balb/c
mice were put on a control or 1% DHA diet for three weeks and 24 hours prior to evaluation
the mice were instilled with either DM, MWCNT, or SiO 2. Percentage of DHA content
between control and 1% DHA diet. Data presented as mean ± SEM, n=4. *P<0.05 compared
to DM, ++++P<0.0001 compared to different treatments within the same exposure group.
Analyses were done with log-transformed data.
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(1 mg/mouse). Twenty-four hours after instillation, whole lung lavages were performed in
order to assess inflammatory responses and collect lung immune cells. Confirmation of
fatty acid composition within red blood cells was sent for analysis (Table 2) which
confirmed an increase in DHA content within the DHA-fed mice compared to the control
diet (Figure 7).
Lung injury and inflammation were assessed by analyzing LDH levels (indicative
of overall pulmonary cellular damage), protein concentrations (a marker for epithelial cell
damage), and various inflammatory and pro-resolving cytokines within the lung lavage
fluid (LLF). Results showed that DHA-fed mice exposed to DM-only had a trending
decrease in both LDH levels and protein concentration within the LLF, suggesting basal
level protection (Figure 8 A,B). However, when mice were exposed to either particle there
was an increase in lung damage as indicated by increased LDH and protein in the LLF of
mice on the DHA diet (Figure 8 A,B). There were also consistent increases in inflammatory
cytokines within the LLF; such as IFNγ, IL-1β, TNFα, and IL-33 (Figure 8C), with mice
exposed to either particle while on the DHA diet. IL-6 levels had a trending increase in
mice exposed to MWCNT on the DHA diet; however, IL-6 levels were decreased in SiO2exposed mice on the DHA diet when compared to control mice (Figure 8C). There were
some differences between the control and DHA diet-fed mice for the exposure groups for
IL-13 levels; however, both IL-13 and IL-10 levels were extremely low overall. These
results indicate increased lung damage of mice on the DHA diet with acute particle
exposure compared to the control diet which may suggest that the increased pulmonary
injury and inflammation may be due to increased recruitment of other inflammatory cells
at this timepoint.
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Figure 8. Assessment of lung damage and cytokine analysis within the LLF for
prophylactic acute model. Balb/c mice were put on a control or 1% DHA diet for three
weeks and 24 hours prior to evaluation the mice were instilled with either DM, MWCNT,
or SiO2. (A) LDH release and (B) protein concentration were assessed for lung damage.
(C) Inflammatory cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10,
and IL-13, and IL-6 were analyzed in the LLF. Data presented as mean ± SEM, n=5-6.
*P<0.05, **P<0.01, ***P<0.001, **** P<0.0001 compared to DM, + compared to different
diet within the same exposure group. Analyses were done with log-transformed data.
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Figure 9. Analysis of cell types within LLF for prophylactic acute model. Balb/c mice were
put on a control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation the mice
were instilled with either DM, MWCNT, or SiO 2. Percentage of cell types were assessed
via cytospins of cell differentials. Data presented as mean ± SEM, n=5-6. *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001 comparing exposures within same diet, + comparing
the same exposure between diets. Analyses were done with log-transformed data.
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3.3.5 DHA’s effect on pulmonary cells in vivo
Since there was an increase in inflammatory mediators within the LLF, the cell differentials
were determined (Figure 9). Mice instilled with DM-only had predominantly AM
regardless of diet. Both particles also had AM present; however, they induced granulocyte
recruitment that were dominated by neutrophils with a few eosinophils. There were no
differences between the total number of cells when comparing the control diet and DHA
diet (data not shown). These results confirmed an increase in inflammatory signaling within
the DHA-fed mice which could indicate that mice on the DHA diet have an enhanced
response to particle exposure compared to mice on the control diet.
The analysis of AM and the impacts due to DHA are crucial to understanding DHA
as a potential treatment for particle-induced inflammation since macrophages are key
players in phagocytosing foreign materials. The in vitro studies indicated that DHA could
decrease particle-induced IL-1β release from M0 AM. Therefore, AM were isolated from
the LLF and cultured ex vivo in order to assess IL-1β release (Figure 10A). Mice instilled
with DM-only while on the DHA diet had a significant decrease in IL-1β release suggesting
that DHA decreased basal AM inflammatory potential. When mice were instilled with
MWCNT while on the DHA diet there was a significant increase of IL-1β release from AM
compared to mice on the control diet. However, mice on the DHA diet and instilled with
SiO2 showed a trending decrease in IL-1β release. Since IL-1β is due to the activation of
the NLRP3 inflammasome; which can be triggered by LMP, cathepsin release (a product
of LMP) was measured within the LLF as an in vivo indicator of LMP. There was a
significant increase of total cathepsin release within the LLF of mice exposed to either
particle compared to the DM-only mice which was further
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Figure 10. Assessment of LMP for prophylactic acute model. Balb/c mice were put on a
control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation the mice were
instilled with either DM, MWCNT, or SiO2. LMP was assessed through detection of (A)
IL-1β release directly from AM ex vivo, (B) total cathepsin release within the LLF, and (C)
cathepsin B release within the LLF. Data presented as mean ± SEM, n=5-6. *P<0.05,
**P<0.01, ****P<0.0001 compared to DM, + compared to different diet within the same
exposure group. Analyses were done with log-transformed data. CTS, cathepsin.
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increased in mice on the DHA diet regardless of particle exposure (Figure 10B). There
were also trending increases of cathepsin B levels, which has been linked to LMP
specifically, in the LLF for mice on the DHA diet and instilled with either particle (Figure
10C). These results demonstrate an increase in inflammatory cascades with mice on the
DHA diet which is in contrast to the in vitro results as well as the hypothesis that DHA
downregulates particle-induced inflammatory responses.

3.3.6 Alteration of macrophage phenotype by DHA in vivo
The prophylactic treatment of DHA with an acute exposure to MWCNT and SiO 2 exhibited
varying effects on AM from Balb/c mice. The in vitro analysis demonstrated that the impact
of DHA on an acute particle exposure differs between the macrophage phenotypes. In order
to better understand why the in vivo outcomes did not follow the predicted outcomes from
the in vitro studies, changes in macrophage phenotype were examined within lung and
spleen tissues of these mice. Recent studies in our laboratory have shown significant
trafficking of MWCNT into the spleen and changes in immune cell populations; therefore,
spleen tissue was included in this portion of the study. qPCR was performed in order to
examine relative gene expression levels to assess shifts in macrophage phenotype
depending on particle exposure and DHA treatment. As seen in the lung tissue, the
expression levels of most genes were downregulated when analyzing the particle-only
effect (Figure 11A); however, there was a shift in macrophage phenotype when assessing
the DHA diet effect (Figure 11B). There was a dominant phenotype shift towards M2c with
mice exposed to MWCNT and on the 1% DHA diet which is indicative of pro-resolving
tissue repair and matrix deposition, but a trending
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Figure 11. Impact of particle exposure and DHA treatment on macrophage phenotype for
prophylactic acute model. Balb/c mice were put on a control or 1% DHA diet for 3 weeks
and 24-hours prior to evaluation the mice were instilled with either DM, MWCNT, or SiO 2.
Relative gene expression of control diet MWCNT or SiO2 mice were normalized to control
diet DM mice for assessment of particle effect in (A) lung and (C) spleen tissues. Relative
gene expression of 1% DHA diet mice were normalized to corresponding control diet mice
for assessment of diet effect in (B) lung and (D) spleen tissues. Each bar within the heat
maps consist of 5-6 mice for lung tissue and 4 mice for spleen tissue.
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upregulation of M2b markers. When mice were exposed to SiO 2 while on the 1% DHA
diet there was a dominant phenotype shift towards M1 and M2b which have overlapping
roles indicative of increased inflammatory signaling; however, a trending upregulation of
the M2c phenotype. This indicated that DHA treatment may have enhanced responses in
the MWCNT-exposed mice towards the pro-resolving phenotype compared to that in the
SiO2-exposed mice.
Particles were not anticipated to be present in the spleen at this early timepoint;
however it has been shown that particle exposure can have systemic effects (X.-Y. Li et
al., 2017; Pollard, 2016). The results within the spleen tissue suggest that there was a
trending upregulation in M2c gene expression with mice exposed to the MWCNT, but no
macrophage phenotype shift for mice exposed to SiO2 when assessing a particle-only effect
(Figure 11C). Upon DHA treatment in the spleen tissue, DM-only mice had trending
upregulated M2a gene expression and a trending upregulation of M2c gene expression
which suggested priming of a M2 tissue repair response within the spleen at this time
(Figure 11D). When mice were exposed to MWCNT on the 1% DHA diet there was an
overall downregulation in gene expression in the spleen. However, there was a trending
upregulation of the M2a phenotype for mice on the 1% DHA diet when exposed to SiO 2
(Figure 11D). An upregulation of expression for a few other genes occurred in SiO2exposed mice while on the 1% DHA diet; however, not enough to be indicative of a
dominant macrophage phenotype shift. These results suggest that mice on the 1% DHA
prophylactic diet altered macrophage phenotype responses within both lung and spleen
tissues which differed between particle exposure type. DHA treatment pushed macrophage
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responses towards an M2c phenotype which supported the in vitro findings that DHA
impacts the M2c phenotype more than the other phenotypes.

3.3.7 Effect of DHA on lung histopathology in vivo
DHA increased inflammatory signaling cascades within the LLF; however, gene
expression of macrophage phenotypes within tissues after DHA treatment had upregulation
of pro-resolving phenotypes. Therefore, investigation of DHA’s impact on particleinduced lung pathology was assessed. Lung tissue sections from these mice were stained
with Masson’s trichrome and scored for histological analysis. The degree of lung
inflammation was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect and
4 indicating extreme lung inflammation. As seen in Figure 12A, there was a consistent
trending increase in lung inflammation with mice exposed to either particle while on the
DHA diet compared to the control diet-fed mice. Airway thickness was also measured in
similar sized airways. Upon DHA treatment, there was a trending decrease of airway
thickness for MWCNT-exposed mice when compared to the control diet-fed mice (Figure
12B). SiO2-exposed mice had a significant increase in airway thickness for mice on the
DHA diet compared to the control diet. Figure 12C shows representative photomicrographs
of airways and surrounding tissues. These results indicated that DHA did not protect the
lung pathology when exposed to either inflammatory particle after 24-hours.
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Figure 12. Histopathology analysis of lung tissue for prophylactic acute model. Balb/c
mice were put on a control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation
the mice were instilled with either DM, MWCNT, or SiO 2. (A) Pathology was scored
blinded by two observers. Data presented as median ± SEM, n=3. (B) Airway thickness
was measured blinded. Data presented as mean ± SEM, n=3. (C) Representative images
(10x) of Masson’s trichrome-stained lung airway sections. *P<0.05, **P<0.01 compared to
DM, + compared to different diet within the same exposure group. Arrows indicate particle
encapsulation, blue staining indicates collagen deposition.
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3.4 Discussion
It has been reported that DHA has anti-inflammatory properties; however, its impacts on
particle-induced inflammation, especially in regard to comprehensive evaluations of
murine strains and macrophage phenotype, remain to be determined. When macrophages
take up particles that can cause LMP; such as MWCNT and SiO2, this can initiate
inflammation, which macrophages can either aid or suppress through phenotype shifts. It
has yet to be determined if particle-induced inflammation can be treated by DHA due to
impacting macrophage phenotype and/or altering LMP. The current in vitro studies showed
that particles had differential effects on individual macrophage phenotypes and DHA
treatment could downregulate the inflammatory cascade in some but not all phenotypes.
The current results provided new information on the response of individual
macrophage phenotypes to two toxic/inflammatory particles as well as the effects of DHA
on the response of the individual macrophage phenotypes to the two particles. While the
main focus of the studies was to explore potential anti-inflammatory mechanisms of DHA
on macrophages and macrophage phenotypes, the study also clearly demonstrated
variability in responses of the phenotypes to particles alone without DHA treatment that
should help better understand outcomes in vivo. For example, differences in MWCNT and
SiO2 toxicity were most apparent in M2c macrophages and least in M1 macrophages. M2c
macrophages also had the greatest particle-induced IL-1β release. The M1 macrophages
had the lowest particle uptake, suggesting that high levels of M1 macrophages in vivo could
result in lower particle uptake. The pattern of LMP followed roughly the same order since
both MWCNT and SiO2-induced LMP was greatest in M2c macrophages and lowest in M1
macrophages, consistent with the relative order of IL-1β release. Therefore; particle uptake,
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LMP and IL-1β release were relatively consistent. It should be noted that these studies were
conducted using primary alveolar macrophages isolated from Balb/c mice using previously
published techniques to polarize macrophages, as described in Methods. Whether the same
pattern would occur in other strains of mice remains to be determined.
The in vitro treatment of macrophages with DHA indicated that DHA was able to
slightly decrease cellular cytotoxicity caused by particles within each macrophage
phenotype, resulting in less IL-1β release. DHA also altered particle uptake depending on
macrophage phenotype as well as the type of the particle which tended to increase for SiO2
uptake upon DHA treatment. These results were consistent with the ability of DHA to
decrease LMP caused by both particles which mechanistically explains the decreased IL1β release. Even though the highest levels of toxicity, IL-1β release, and LMP caused by
particles were in the M2c phenotype, this same phenotype had the most protection caused
by DHA treatment. This indicated that DHA has the capability to decrease the most robust
inflammatory response caused by particles.
The current studies showed differences between the MWCNT- and SiO2-exposed
models both in vitro and in vivo upon DHA treatment which might be attributed to their
differences in particle size, charge, morphology, or composition. MWCNT are
hydrophobic rolled graphene sheets with a greater surface area per mass that are 1–100 nm
in at least one dimension in size (Saifuddin et al., 2013). In contrast, the surface of SiO2 is
hydrophilic and commonly found in nature as quartz which can be the size of <10 μm
(Dyachenko et al., 2004; Pollard, 2016). Whether some of the differences that were
observed in the current studies are due to particle size, composition, or surface
characteristics remains to be determined. Importantly, the current results show that DHA
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treatment does not benefit all particle-exposure models which could also vary between cell
type and mouse strain.
The ability of AM to phagocytose these particles affected their LMP in vitro which
differed between the various phenotypes, indicating that the phagolysosomal membrane
within each of the phenotypes was altered. One possible explanation could be differences
in scavenger receptors between the various macrophage phenotypes which in turn affects
how they respond to phagocytosing particles. It has been shown that there is an increase of
CD36 in M1 macrophages and an increase in both SR-A1 and CD163 in M2a macrophages
(Canton et al., 2013). One study reported that STAT3 induces CD36 expression in a chronic
lymphocytic leukemia model and that fatty acid uptake is facilitated by STAT3-mediated
expression of CD36 (Rozovski et al., 2018). In a gastric cancer model, STAT3 was an
important regulator of CD163 (Cheng et al., 2017). In the current in vitro studies, we
observed an increase in particle uptake of MWCNT when exposed to DHA in M2a and of
SiO2 in M2a, M2b, and M2c which could suggest that the other M2 subsets also have an
increase of CD163 which could be altered by STAT3. However, there may be differences
in either STAT3 or CD163 expression in the M2b and M2c subsets because there was a
decrease in MWCNT uptake when exposed to DHA. While scavenger receptors are known
to be responsible for the uptake of SiO2 (Hamilton et al., 2006), scavenger receptors for
MWCNT exposure are less well-described. There is also the possibility that fatty acid
incorporation into the membranes occurs differently between the macrophage phenotypes
The type of particle exposure could potentially alter these expressions as well depending
on the differences in physiochemical properties as indicated above. For the most part, DHA
treatment had a beneficial effect on AM in vitro after a 24-hour particle exposure,
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specifically in the M2c phenotype. However; the in vivo 24-hour particle exposure study
showed a different outcome.
The current in vivo study where mice exposed to particles for 24-hours while on a
prophylactic 1% DHA diet caused an increase in lung damage and inflammatory cytokines
for mice on the DHA diet. There is a constant cross-talk between macrophages and
epithelial cells within the lungs. One study reported that DHA-fed mice had a significant
increase of amphiregulin (AREG); which promotes the normal growth of epithelial cells
by interacting with epidermal growth factor receptor (EGFR), when exposed to dust extract
in lung tissue compared to the control diets (Nordgren et al., 2018). When DHA-fed mice
were exposed to particles in the current study there was an increase in neutrophils,
increased protein concentration, and increased IL-33 levels in the LLF which indicates that
DHA could be affecting epithelial cells within the lung tissue at this particular timepoint.
Efferocytosis (of neutrophils) by AM could have occurred, initiating a signaling cascade
with secretion of TGFβ and prostaglandin E2 (PGE2) (Allard et al., 2018). A characteristic
of the M2c phenotype is increased TGFβ and the current in vivo study had increased M2c
gene expression within the lung and spleen tissues upon DHA treatment. One study
reported that when airway epithelial cells were exposed to LPS, COX2 was upregulated
resulting in an increase of PGE2. PGE2 can bind to receptors on AM leading to increased
suppressor of cytokine signaling (SOCS)-3 proteins where AM secrete SOCS3 and
epithelial cells uptake SOCS3 in turn inhibiting STAT3 (Speth et al., 2016). It has been
shown that the IL-6/STAT3 pathway is inhibited in M1 macrophages which was confirmed
by showing that M0 macrophages turned into M1 macrophages with the inhibition of IL6/STAT3. However; IL-6/STAT3 is activated in M2a macrophages (Yin et al., 2018). IL-
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6 levels within the LLF of the current in vivo study had opposite effects upon DHA
treatment between MWCNT- and SiO2-exposed mice. In the current in vitro studies, we
observed distinct differences between the M1 and M2 subset phenotypes; including
cytotoxicity, IL-1β release, particle uptake, and LMP. These differences in phenotype
could be linked to the alterations of IL-6/STAT3. This pathway should be researched
further between the different macrophage phenotypes upon particle exposure.
DHA has been reported to inhibit STAT3 in a PPARγ/SOCS3-dependent manner
when exposed to Helicobacter pylori infection in a human gastric cancer AGS cell model
(Ji et al., 2016). The current in vivo study had increased inflammatory markers when mice
were fed the DHA diet which could mean that DHA is inhibiting STAT3 which could
increase a M1 dominant phenotype at this particular timepoint for cell signaling. This might
indicate that DHA treatment caused an increased inflammatory response in a shorter period
of time in order to quickly resolve damage caused by particles. In a different gastric cancer
tumor model, M2 macrophages positively correlated with IL-6 expression and when
STAT3 was knocked down there was a decrease in IL-10 and TGFβ cytokines; which are
linked to overall M2 and specifically M2c phenotypes, respectively (Fu et al., 2017). The
current in vivo study showed that DHA increased IL-6 levels within the LLF of DM-only
and MWCNT-exposed mice and increased M2c gene expression in lung tissue. DHA
appears to be impacting the M2c phenotype more than the other subsets as indicated both
in vitro and in vivo throughout these studies which further supports the notion that
additional phenotypes, other than M1 and M2a, should be included in future studies. The
M2c phenotype seems to process particle exposures differently. STAT3 has also been
found to directly modulate lysosomal membrane components to induce lysosomal
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leakiness and upregulate cathepsin B, which resulted in cell death within mammary gland
epithelial cells (Lloyd-Lewis et al., 2018). The current in vivo study showed an increase in
both total cathepsin and cathepsin B release in the LLF of 1% DHA-fed mice when exposed
to particles. This also correlated to the current in vitro studies where there was an increase
in LMP when treated with DHA and exposed to particles within M1 and M2a phenotypes
which means this could be linked to alterations of STAT3 between the macrophage
phenotypes.
In summary, there is still much to be determined when assessing the differences
between macrophage phenotypes when exposed to various particles. The phenotypes do
not act the same when exposed to particles as shown here by assessing cytotoxicity, particle
uptake, various inflammatory mediators, and LMP in vitro. DHA aids in suppressing
inflammation and increasing particle uptake; however, it varies between phenotypes. After
24-hours of particle exposure in vivo, DHA had a rapid response to particle infiltration
within the body to begin signaling for inflammatory mediators compared to the control
diet. The current in vivo study indicated that further research needs to be done in order to
assess the impacts of DHA on epithelial cells for this inflammatory signaling cascade;
however, DHA did alter macrophage phenotype gene expression patterns within various
tissues suggesting that it is preparing the body to shift to a tissue-resolving phase. The goals
of the in vitro studies were to assess the different macrophage phenotype responses to
particle exposure and the impacts of DHA treatment. However, the current in vivo study
indicated a crosstalk among different cells which the in vitro studies could not have
anticipated which demonstrated that in vitro studies can not always be used to translate
directly into in vivo outcomes. Future research needs to be done to assess the crosstalk
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between epithelial cells and the different macrophage phenotypes with particle-induced
inflammation in vitro. Semi-acute and chronic in vivo studies need to be completed in order
to assess if DHA can resolve the inflammation quicker when compared to the control diet.
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Chapter 4
DHA as a potential prophylactic treatment for semi-acute and
chronic particle-induced inflammation in vivo

4.1 Abstract
Chronic inflammation is a vital contributing factor to pulmonary diseases which can be
triggered by exposure to occupational and man-made particles. Unfortunately, there are no
established treatments to block the cycle of chronic inflammation. One potential treatment
shown to have anti-inflammatory capabilities is the dietary supplement docosahexaenoic
acid (DHA); an omega-3 polyunsaturated fatty acid found in fish oil. DHA’s antiinflammatory mechanisms are unclear for particle-induced inflammation; therefore, this
study evaluated DHA as a prophylactic treatment for semi-acute and chronic particleinduced inflammation in vivo. Balb/c mice were fed a control or 1% DHA-containing diet
for 5 weeks (semi-acute) or 18 weeks (chronic). At week 4 (semi-acute) or weeks 2, 3, 4,
and 5 (chronic) the mice were oropharyngeal instilled with dispersion media, a highly
inflammatory multi-walled carbon nanotube (MWCNT), or crystalline silica (SiO2). One
week (semi-acute) or 13 weeks (chronic) after instillation inflammatory signaling within
the lung lavage fluid, impacts on phagolysosomal membrane permeability, shifts of
macrophage phenotype gene expression (M1, M2a, M2b, and M2c), and pulmonary
histopathology were determined. Results indicated that DHA had a consistent antiinflammatory effect with mice exposed to MWCNT in both in vivo exposure models which
could be linked to stabilizing the phagolysosomal membrane in alveolar macrophages and
shifting macrophage phenotype in spleen tissue. Mice exposed to SiO 2 while on the DHA
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diet had varying effects which indicated that DHA treatment may depend upon certain
inflammatory particle exposures. Therefore, DHA was shown to be effective, but the
outcomes depend on the model under investigation.

4.2 Introduction
More than one billion people worldwide suffer from either acute or chronic respiratory
conditions. This leads to respiratory diseases making up five of the thirty most common
causes of death and over one billion people inhale polluted outdoor air; therefore,
contributing to this respiratory impairment (Forum of International Respiratory Societies,
2017). While the vast majority of concern with outdoor air pollution is related to fossil fuel
combustion-generated particles; typically known as particulate matter less than 2.5 µm
(PM2.5), there are many other occupational and man-made particles of specific concern that
have a diameter of less than 2.5 µm and can travel down into the alveolar regions of the
lung when inhaled. These include various engineered nanomaterials (ENM); such as multiwalled carbon nanotubes (MWCNT), and crystalline silica (SiO2).
The use of ENM has been rapidly increasing in many commercial products; such
as cosmetics, electronics, and medicine (Ray et al., 2019). One of the most common ENM
used for these products are MWCNT which are nano-sized, meaning that it has at least one
dimension in the size range of 1–100 nm (Yokel & MacPhail, 2011). Some MWCNT have
been linked to lung fibrosis and granuloma formation (Lam et al., 2006). In contrast to the
nanosized MWCNT, SiO2 is a micron-sized particle primarily generated in occupational
settings. Exposure to inhalable SiO2 particles (<10 μm in size) are known to cause silicosis;
an established world-wide occupational health problem, and autoimmune disorders
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(Pollard, 2016). However, there are no known prophylactic treatments to reduce
inflammation caused by either of these particles.
It has been reported that there has been a 60% increase between 2007 and 2012 in
the dietary intake of fish oil supplementation (Clarke et al., 2015). Docosahexaenoic acid
(DHA); an omega-3 polyunsaturated fatty acid that is found in fish oil, has been shown to
have various anti-inflammatory capabilities. Studies have reported that DHA is beneficial
throughout life; such as improving cognitive capabilities during fetal development and
improving outcomes for cardiovascular disease and Alzheimer’s disease (Devassy et al.,
2016; Swanson et al., 2012). Nevertheless, research of how DHA effects particle-induced
lung inflammation is currently limited.
The objectives of the current studies were to evaluate the ability of DHA to reduce
pulmonary inflammation caused by MWCNT and SiO 2. The use of these two different
particles provided the opportunity to examine the effects of DHA on particles with reported
differences in immune mechanisms (Ray et al., 2019) within time courses that represented
both moderate and high levels of particle doses. The studies used a 1% DHA prophylactic
treatment; which has been previously shown to be effective in a Lupus-prone mouse model
(Bates et al., 2016), but here we used the wildtype Balb/c murine model which is considered
more Th2 prone (Watanabe et al., 2004). In addition to typical markers of lung
inflammation we also examined shifts in macrophage phenotype in the lung and in the
spleen for a systemic immune organ assessment. The hypothesis of this chapter is that DHA
will decrease pulmonary inflammatory markers in response to particle-induced
inflammation. In addition, the effects of DHA will be more effective in treating MWCNT
than SiO2 in the Balb/c murine exposure model.
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4.3 Results
4.3.1 Effect of DHA on pulmonary cells and lung injury
In order to simulate a semi-acute exposure model, Balb/c mice were placed on either a
control or 1% DHA diet for a total of 5 weeks. At week 4, mice were oropharyngeal
instilled once with either dispersion media-only vehicle (DM; 50 µl/mouse), MWCNT (50
µg/mouse), or SiO2 (1 mg/mouse). One week after particle exposure, whole lung lavages
were performed in order to collect immune cells that reside within the lung airspaces and
assess inflammatory responses induced by particle exposure. The overall study design is
depicted in Figure 13A. Confirmation of fatty acid composition within red blood cells was
sent for analysis (Table 3) which confirmed an increase in DHA content within the DHAfed mice compared to the control diet (Figure 14A).
The results of the semi-acute exposure model demonstrated that the mice had an
increase in alveolar macrophages (AM) regardless of particle exposure and diet treatment
(Figure 15A). There was no significant difference between the total number of cells when
comparing the control diet and DHA diet for AM (data not shown). There was a slight
increase in eosinophils and neutrophils in SiO2-exposed mice for both diets compared to
other exposure groups; however, AM remained the dominant cell type (Figure 15A). Mice
exposed to MWCNT while on the DHA diet had less cellular toxicity in the lung lavage
fluid (LLF) compared to MWCNT mice on the control diet. This was shown by a trending
decrease of LDH levels (Figure 15B); indicative of overall damage of pulmonary cells, and
a trending decrease of protein concentration (Figure 15C); indicative of epithelial cell
damage within the lungs. Analysis of inflammatory markers
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Figure 13. Experimental designs of prophylactic semi-acute & chronic models. (A) Balb/c
mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were instilled with
either DM-only, MWCNT, or SiO2 and euthanized 1 week later; semi-acute model. (B) Balb/c
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later; chronic model.
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P7d (Dr. Pestka’s Lab Analyzed):
Note – only the January harvest (see reason in excel sheet)

Experimental Groups

Fatty Acid
14:0
15:0
16:0
16:1 (ω-7) trans
16:1 (ω-7) cis
16:1 (ω-9)
17:0
18:0
18:1 (ω-9)
18:1 (ω-7)
18:2 (ω-6)
18:3 (ω-3)
20:0
20:4 (ω-6)
20:5 (ω-3)
22:0
22:4 (ω-6)
22:5 (ω-6)
22:5 (ω-3)
22:6 (ω-3)
24:0
24:1 (ω-9)

DM

Control Diet
MWCNT

0.24 ± 0.03
0.07 ± 0.01
36.06 ± 0.83
0.03 ± 0.01
0.33 ± 0.01
0.24 ± 0.02
0.22 ± 0.02
19.16 ± 0.59
17.30 ± 0.29
1.25 ± 0.08
5.19 ± 0.23
0.44 ± 0.03
0.18 ± 0.03
13.05 ± 0.69
0.00 ± 0.00
0.89 ± 0.04
1.54 ± 0.08
1.63 ± 0.09
0.10 ± 0.01
1.79 ± 0.16
0.14 ± 0.01
0.09 ± 0.02

0.29 ± 0.03
0.09 ± 0.01
33.98 ± 1.71
0.04 ± 0.01
0.25 ± 0.02
0.25 ± 0.03
0.27 ± 0.02
18.31 ± 1.55
16.18 ± 0.34
0.96 ± 0.04
5.66 ± 0.21
0.45 ± 0.03
0.21 ± 0.03
15.51 ± 1.96
0.00 ± 0.00
0.82 ± 0.09
1.66 ± 0.20
1.83 ± 0.22
0.14 ± 0.03
2.47 ± 0.49
0.15 ± 0.00
0.09 ± 0.01

SiO2
% of fatty acid
0.23 ± 0.03
0.08 ± 0.01
31.65 ± 0.62
0.03 ± 0.01
0.30 ± 0.04
0.22 ± 0.02
0.21 ± 0.03
16.85 ± 0.89
16.10 ± 0.18
1.17 ± 0.12
5.48 ± 0.28
0.40 ± 0.01
0.17 ± 0.02
18.17 ± 0.91
0.00 ± 0.00
1.01 ± 0.11
1.84 ± 0.11
1.96 ± 0.20
0.16 ± 0.03
3.16 ± 0.22
0.12 ± 0.01
0.07 ± 0.01

DM
in RBC
0.31 ± 0.02
0.07 ± 0.00
37.07 ± 0.82
0.02 ± 0.00
0.40 ± 0.04
0.15 ± 0.01
0.21 ± 0.01
14.06 ± 0.95
14.78 ± 0.48
0.86 ± 0.03
7.80 ± 0.13
0.25 ± 0.01
0.17 ± 0.03
5.14 ± 0.27
1.88 ± 0.18
0.70 ± 0.04
0.31 ± 0.02
0.21 ± 0.04
0.46 ± 0.02
14.58 ± 0.96
0.18 ± 0.01
0.08 ± 0.01

1% DHA Diet
MWCNT

SiO2

0.41 ± 0.03
0.08 ± 0.01
38.20 ± 1.15
0.02 ± 0.00
0.50 ± 0.03
0.22 ± 0.03
0.23 ± 0.03
16.14 ± 1.73
15.48 ± 0.36
1.10 ± 0.09
6.90 ± 0.70
0.24 ± 0.03
0.15 ± 0.04
5.07 ± 0.31
1.75 ± 0.31
0.76 ± 0.01
0.27 ± 0.04
0.16 ± 0.04
0.43 ± 0.02
11.31 ± 1.37
0.17 ± 0.02
0.08 ± 0.01

0.45 ± 0.07
0.09 ± 0.01
38.71 ± 0.66
0.02 ± 0.00
0.46 ± 0.06
0.20 ± 0.01
0.22 ± 0.02
15.67 ± 0.88
15.65 ± 0.44
1.04 ± 0.11
7.21 ± 0.28
0.23 ± 0.01
0.15 ± 0.03
4.69 ± 0.36
1.73 ± 0.17
0.68 ± 0.05
0.29 ± 0.00
0.16 ± 0.02
0.42 ± 0.02
11.26 ± 0.85
0.17 ± 0.00
0.07 ± 0.00

Table 3. Fatty acid composition of red blood cells in prophylactic semi-acute model. Data
presented in a percentage as mean ± SEM, n=3-5.
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Figure 14. Fatty acid analysis within red blood cells of prophylactic semi-acute & chronic
models. Percentage of DHA content between control and 1% DHA diet for prophylactic (A)
semi-acute and (B) chronic exposure models. Data presented as mean ± SEM, semi-acute n=1113, chronic n=4. *P<0.05, **P<0.01 compared to DM; ++++P<0.0001 compared to different
treatments within the same exposure group.
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Figure 15. Pulmonary cells and lung injury analysis in prophylactic semi-acute model.
Balb/c mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were
instilled with either DM-only, MWCNT, or SiO2 and euthanized 1 week later. (A)
Percentage of cell types were assessed via cytospins of cell differentials. (B) LDH and (C)
protein concentration were assessed in the LLF for lung damage. Data presented as mean
± SEM, n=7-9. *P<0.05, **P<0.01, ****P<0.0001 compared to DM, + compared to different
diet within the same exposure group. Analyses were done with log-transformed data.
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in the LLF showed an overall decrease of inflammatory signaling in the DHA-fed mice
when exposed to MWCNT compared to the MWCNT control diet-fed mice; specifically,
a significant decrease of IL-1β and TNFα as well as decreased levels of IFNγ, IL-33, and
IL-6 (Figure 16). In contrast, mice exposed to SiO2 while on the DHA diet had a significant
increase of LDH levels (Figure 15B) and a trending increase of protein concentration
(Figure 15C) compared to the control diet-fed mice. These results positively correlated to
a significant increase of IFNγ levels within the LLF as well as a trending increase of TNFα,
IL-33, and IL-6 levels for these same mice (Figure 16). The increased neutrophils and
eosinophils in SiO2-exposed mice could account for these differences in lung injury. These
results showed that mice with a semi-acute particle exposure to MWCNT while on a
prophylactic 1% DHA diet had decreased lung injury compared to the control diet;
however, there was increased lung damage when mice were exposed to SiO 2 while on the
same DHA diet. This supported our hypothesis that DHA will decrease pulmonary
inflammatory markers more effectively in MWCNT-exposed mice compared to SiO2exposed mice.
To simulate a chronic exposure study, Balb/c mice were placed on either a control
or 1% DHA diet for a total of 18 weeks. At weeks 2, 3, 4, and 5, mice were oropharyngeal
instilled once a week with either DM-only vehicle, MWCNT, or SiO2 as described above.
Thirteen weeks after particle exposure, whole lung lavages were performed and analysis
was completed the same as described above in the semi-acute model. The overall study
design is depicted in Figure 13B. Confirmation of fatty acid composition within red blood
cells was sent for analysis (Table 4) which confirmed an
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Figure 16. Cytokine analysis in prophylactic semi-acute model. Balb/c mice were put on a
control or 1% DHA diet for 5 weeks. At week 4, mice were instilled with either DM-only,
MWCNT, or SiO2 and euthanized 1 week later. Inflammatory cytokines; IFNγ, IL-1β,
TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-6 were analyzed in the
LLF. Data presented as mean ± SEM, n=8-9. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001
compared to DM, + compared to different diet within the same exposure group. Analyses
were done with log-transformed data.
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PC (OmegaQuant):
Experimental Groups

Fatty Acid
14:0
16:0
16:1 (ω-7) trans
16:1 (ω-7)
18:0
18:1 trans
18:1 (ω-9)
18:2 (ω-6) trans
18:2 (ω-6)
18:3 (ω-6)
18:3 (ω-3)
20:0
20:1 (ω-9)
20:2 (ω-6)
20:3 (ω-6)
20:4 (ω-6)
20:5 (ω-3)
22:0
22:4 (ω-6)
22:5 (ω-6)
22:5 (ω-3)
22:6 (ω-3)
24:0
24:1 (ω-9)

DM

Control Diet
MWCNT

0.14 ± 1.05E-04
27.16 ± 3.65E-03
0.10 ± 1.09E-04
0.31 ± 5.16E-04
11.79 ± 2.16E-03
0.21 ± 3.03E-04
19.67 ± 2.95E-03
0.20 ± 1.63E-04
6.60 ± 5.35E-03
0.07 ± 3.72E-05
0.09 ± 1.42E-04
0.18 ± 2.67E-04
0.54 ± 5.01E-04
0.15 ± 1.04E-04
1.12 ± 3.35E-04
21.87 ± 5.97E-03
0.04 ± 6.00E-05
0.19 ± 1.08E-04
2.33 ± 1.58E-03
4.41 ± 7.76E-03
0.07 ± 5.71E-05
2.14 ± 1.76E-03
0.20 ± 8.33E-05
0.42 ± 1.81E-04

0.15 ± 5.74E-05
27.85 ± 4.65E-04
0.09 ± 2.71E-04
0.34 ± 4.61E-04
11.19 ± 1.12E-03
0.22 ± 2.38E-04
20.40 ± 1.57E-03
0.20 ± 2.72E-04
6.22 ± 6.01E-03
0.09 ± 2.71E-05
0.10 ± 8.20E-05
0.17 ± 2.98E-04
0.59 ± 8.76E-04
0.15 ± 9.35E-05
1.04 ± 2.03E-04
21.47 ± 1.13E-02
0.03 ± 2.56E-05
0.17 ± 1.50E-04
2.41 ± 7.04E-04
4.37 ± 9.18E-03
0.08 ± 1.41E-04
2.10 ± 3.03E-03
0.19 ± 4.50E-05
0.37 ± 2.46E-04

SiO2
DM
% of fatty acid in RBC
0.13 ± 1.64E-04
0.28 ± 1.28E-04
27.61 ± 2.26E-03
30.90 ± 7.81E-04
0.12 ± 1.82E-04
0.06 ± 2.70E-04
0.31 ± 7.04E-04
0.31 ± 4.32E-04
11.29 ± 2.48E-03
10.52 ± 1.91E-03
0.24 ± 1.90E-04
0.25 ± 3.63E-04
20.27 ± 2.35E-03
18.55 ± 1.68E-03
0.32 ± 3.70E-04
0.28 ± 5.57E-04
6.78 ± 7.16E-03
9.20 ± 3.52E-03
0.07 ± 6.95E-05
0.07 ± 8.99E-05
0.13 ± 1.93E-04
0.13 ± 2.19E-04
0.20 ± 4.95E-04
0.20 ± 3.30E-04
0.59 ± 1.10E-03
0.43 ± 4.83E-04
0.15 ± 1.62E-04
0.14 ± 6.02E-05
1.03 ± 2.84E-04
1.19 ± 9.82E-05
21.07 ± 1.16E-02
5.06 ± 9.52E-04
0.03 ± 7.14E-05
2.63 ± 3.65E-03
0.17 ± 2.51E-04
0.20 ± 1.05E-04
2.38 ± 6.67E-04
0.13 ± 8.04E-05
4.26 ± 7.17E-03
0.02 ± 7.14E-05
0.08 ± 8.38E-05
0.55 ± 3.15E-04
2.20 ± 3.44E-03
18.27 ± 4.48E-03
0.18 ± 3.89E-04
0.24 ± 9.70E-05
0.38 ± 7.27E-04
0.39 ± 2.95E-04

1% DHA Diet
MWCNT

SiO2

0.31 ± 1.37E-04
30.21 ± 2.31E-03
0.08 ± 2.14E-04
0.36 ± 7.35E-04
10.54 ± 2.63E-03
0.21 ± 1.60E-04
18.49 ± 3.72E-03
0.27 ± 8.06E-04
9.02 ± 1.79E-03
0.03 ± 5.12E-05
0.13 ± 1.01E-04
0.20 ± 3.62E-04
0.45 ± 6.83E-04
0.16 ± 1.29E-04
1.18 ± 2.49E-04
4.76 ± 1.50E-03
2.65 ± 3.93E-03
0.15 ± 6.36E-05
0.15 ± 2.70E-04
0.03 ± 3.01E-05
0.59 ± 2.83E-04
18.57 ± 4.95E-03
0.19 ± 8.79E-05
0.28 ± 9.04E-05

0.28 ± 1.72E-04
31.69 ± 4.82E-04
0.09 ± 1.33E-04
0.39 ± 8.26E-04
10.09 ± 2.07E-03
0.22 ± 1.28E-04
18.90 ± 5.36E-03
0.23 ± 4.07E-04
8.46 ± 4.30E-03
0.06 ± 5.60E-05
0.12 ± 2.34E-04
0.19 ± 4.18E-04
0.42 ± 4.07E-04
0.15 ± 1.61E-04
1.31 ± 6.25E-04
5.30 ± 4.08E-03
2.65 ± 3.87E-03
0.16 ± 1.84E-04
0.11 ± 1.76E-04
0.02 ± 1.07E-04
0.61 ± 5.56E-04
18.10 ± 5.98E-03
0.19 ± 1.73E-04
0.24 ± 9.95E-05

Table 4. Fatty acid composition of red blood cells in prophylactic chronic model. Data
presented in a percentage as mean ± SEM, n=4.
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increase in DHA content within the DHA-fed mice compared to the control diet (Figure
14B).
The results of the chronic exposure model showed that the dominant cell type
within the LLF was AM regardless of diet and particle exposure; however, there was also
a slight overall increase in lymphocytes (Figure 17A). The SiO2-exposed mice also had an
increase in neutrophils regardless of diet (Figure 17A) compared to the other exposure
groups which was similar to the semi-acute study. Mice on the DHA diet and exposed to
MWCNT had trending decreased lung damage as assessed by LDH (Figure 17B) and
protein concentration (Figure 17C) within the LLF. These results also matched a decrease
in overall inflammatory cytokines within the LLF for the same treatment and exposure
groups; specifically, a significant decrease of TNFα and a decrease of IFNγ, IL-1β, IL-33,
and IL-6 levels (Figure 18). The SiO2-exposed mice while on the DHA diet had increased
lung damage (significantly increased LDH levels; Figure 17B, and increased protein
concentration; Figure 17C) as well as increased inflammatory cytokines (Figure 18).
However, IL-1β levels within the LLF of SiO2-exposed mice on the DHA diet were
decreased compared to control diet. These results indicated that mice on the prophylactic
1% DHA diet with a chronic particle exposure to MWCNT had less lung damage compared
to the control-fed mice; however, the same DHA treatment was not protective of mice
exposed to SiO2 which also supported our hypothesis.
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Figure 17. Pulmonary cells and lung injury analysis in prophylactic chronic model. Balb/c
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. (A)
Percentage of cell types were assessed via cytospins of cell differentials. (B) LDH and (C)
protein concentration were assessed in the LLF for lung damage. Data presented as mean
± SEM, n=4-5. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared
to different diet within the same exposure group. Analyses were done with log-transformed
data.
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Figure 18. Cytokine analysis in prophylactic chronic model. Balb/c mice were put on a
control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were instilled with either
DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. Inflammatory cytokines;
IFNγ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-6 were
analyzed in the LLF. Data presented as mean ± SEM, n=4-5. *P<0.05, **P<0.01,
***P<0.001, ****P<0.0001 compared to DM, + compared to different diet within the same
exposure group. Analyses were done with log-transformed data.
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4.3.2 Alteration of LMP due to DHA
As expected, AM were the dominate cell present within the LLF of the mice for both the
semi-acute and chronic exposure models. AM are the primary innate immune cell in the
lung responsible for the clearing of foreign material; such as inhalation of MWCNT and
SiO2. When AM phagocytose these particles it can lead to phagolysosomal membrane
permeabilization (LMP) which releases various lysosome-specific proteases; such as
cathepsins, into the cytosol. In turn, this initiates NLRP3 inflammasome activation; which
has been associated with the presence of cathepsin B in particular, eventually leading to
IL-1β release (Schroder & Tschopp, 2010; Strowig et al., 2012). Therefore, isolated AM
were cultured ex vivo to measure IL-1β release and the presence of cathepsins within the
LLF were measured to potentially explain the differences between particles in the
responses to DHA treatment.
The semi-acute particle exposure model indicated that there was a significant
decrease in IL-1β release ex vivo from AM for DHA mice exposed to DM-only compared
to control diet (Figure 19A); however, there was no difference between diets for total
cathepsin release (Figure 19B) and a slight increase in cathepsin B release (Figure 19C) for
these same mice. There were no differences between diets when exposed to either particle
for IL-1β release ex vivo from AM (Figure 19A), total cathepsin levels within the LLF
(Figure 19B), or cathepsin B release within the LLF (Figure 19C). These results suggested
that the prophylactic 1% DHA treatment did not appear to significantly affect the
phagolysosomal membrane at this particular timepoint in Balb/c mice for a semi-acute
particle exposure.
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Figure 19. Assessment of LMP in prophylactic semi-acute model. Balb/c mice were put on
a control or 1% DHA diet for 5 weeks. At week 4 mice were instilled with either DM-only,
MWCNT, or SiO2 and euthanized 1 week later. LMP was assessed through detection of
(A) IL-1β release directly from AM ex vivo, (B) cathepsin release within the LLF, and (C)
cathepsin B release within the LLF. Data presented as mean ± SEM, n=5-7 (A), n=8-9
(B,C). *P<0.05, **P<0.01, ***P<0.001 ****P<0.0001 compared to DM, + compared to
different diet within the same exposure group. Analyses were done with log-transformed
data. CTS; cathepsin.
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Figure 20. Assessment of LMP in prophylactic chronic model. Balb/c mice were put on a
control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were instilled with either
DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. LMP was assessed through
detection of (A) IL-1β release directly from AM ex vivo, (B) cathepsin release within the
LLF, and (C) cathepsin B release within the LLF. Data presented as mean ± SEM, n=4-5.
*P<0.05, **P<0.01, ***P<0.001, **** P<0.0001 compared to DM, + compared to different
diet within the same exposure group. Analyses were done with log-transformed data. CTS;
cathepsin.
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For the chronic particle exposure model, there was a significant decrease in IL-1β
release ex vivo from AM of the DHA-fed mice regardless of particle exposure (Figure
20A). This decreased trend continued when total cathepsin and cathepsin B levels were
assessed within the LLF of SiO2-exposed mice while on the DHA diet (Figure 20 B,C).
These results positively correlate to the decreased IL-1β release within the LLF as
described earlier (Figure 18) for these same mice. Mice exposed to MWCNT had no
difference between diets for total cathepsin release (Figure 20B), but had a slight decrease
of cathepsin B release (Figure 20C) within the LLF. These results indicated that a longterm prophylactic 1% DHA diet improved the stability of the phagolysosomal membrane
during a chronic exposure to inflammatory particles when compared to the control diet
supporting our hypothesis that DHA could decrease pulmonary inflammatory markers.

4.3.3 DHA shifts macrophage phenotype
Since DHA treatment had effects on AM that varied between the different particle exposure
models, alterations of macrophage phenotypes were assessed. Various signaling factors;
such as cytokines and immune complexes, generate different macrophage phenotypes that
are broadly defined as classically activated, “pro-inflammatory” M1 and alternatively
activated, “anti-inflammatory” M2. The signaling factors determine which macrophage
phenotype is dominant to regulate the overall response to foreign particles. Depending on
the overall environment present during particle exposure, macrophages could either be
aiding in inflammation or suppressing inflammation through phenotype shifts (Byrne et al.,
2015; Italiani & Boraschi, 2014; Labonte et al., 2014). Information on the impacts of DHA
with macrophage phenotype in regard to particle-induced inflammation is lacking,
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especially when analyzing the understudied M2b and M2c subsets. Therefore, macrophage
phenotypes were evaluated within the lung and spleen tissues to determine local and
systemic effects since recent studies in our laboratory have shown trafficking of MWCNT
into the spleen and changes in immune cell populations. There will be a mixture of
macrophage phenotypes present under any condition, therefore it is important to appreciate
that these studies represent a snap-shot in time to assess the shifts in phenotype between
particle exposure as well as DHA treatment.
When the effect of particle-only exposure was assessed within the lung tissue of
the semi-acute model there was a downregulation of gene expression for the majority of
the macrophage phenotype markers (Figure 21A). The DHA diet altered this gene
expression within the lung tissue by bringing most of those same genes closer to baseline
levels, indicating that the gene expressions were similar for both control and DHA-fed
mice. There were various genes that were upregulated by DHA treatment in the lung tissue
as well; however, not enough to clearly distinguish a specific macrophage phenotype shift
at this particular timepoint (Figure 21B). The particle-only effect within the spleen tissue
of mice exposed to MWCNT had a trending upregulation in the M1 markers described as
an increase in two of the four genes. Within the spleen tissue of mice exposed to SiO2 there
was a dominant upregulation in gene expression markers for the M1 phenotype as indicated
by an increase of at least three of the four genes. These same mice also had a trending
upregulation in M2a markers (Figure 21C). Exposure to the DHA diet altered these
phenotypes within the spleen tissue by downregulating gene expression of the M1 markers
for both MWCNT and SiO2 exposures indicating a
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Figure 21. Impact of particle exposure and DHA treatment on macrophage phenotype in
prophylactic semi-acute model. Balb/c mice were put on a control or 1% DHA diet for 5
weeks. At week 4, mice were instilled with either DM-only, MWCNT, or SiO2 and
euthanized 1 week later. Relative gene expression of control diet MWCNT or SiO 2 mice
were normalized to control diet DM-only mice for assessment of particle effect in (A) lung
and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized to
corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen
tissue. Each bar within the heat maps consist of 5-6 mice for lung tissue and 4-5 mice for
spleen tissue.
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decrease in the pro-inflammatory phenotype, supporting our hypothesis (Figure 21D).
Gene expression levels were upregulated in various M2 markers for both particle exposure
groups; however, not enough to distinguish one particular M2 subset as dominant in the
spleen tissue at this time. These results indicated that the prophylactic 1% DHA treatment
brought the gene expression levels back to baseline more rapidly within the lung tissue
during a semi-acute particle exposure. It also suggested that DHA decreased the
inflammatory markers within the spleen tissue of these same mice.
The particle-only effect within the lung tissue of the chronic model showed a
dominant downregulation of almost all gene expressions regardless of macrophage
phenotype or particle exposure. A few genes were upregulated within each phenotype
separately of these mice; however, not enough to distinguish a specific phenotype shift
(Figure 22A). DHA treatment in the lung tissue did not alter the macrophage phenotype of
MWCNT-exposed mice, but it did change in the SiO2-exposed mice which showed a
trending upregulation for the M2b subset (Figure 22B). The particle-only effects within the
spleen tissue of MWCNT-exposed mice were a mixture of either closer to baseline levels
or downregulated gene expression. However; for SiO 2-exposed mice there was a trending
upregulation in M2b gene expression in the spleen tissue (Figure 22C). DHA treatment
altered these gene expression levels in the spleen tissue by having a dominant macrophage
phenotype shift towards the M2c phenotype for both DM-only and MWCNT exposure
groups. Upon DHA treatment in the spleen tissue, there was a dominant macrophage
phenotype shift towards M2a and a trending upregulation of M2c for SiO 2-exposed mice
(Figure 22D). Both the M2a and M2c phenotypes have overlapping marker
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Figure 22. Impact of particle exposure and DHA treatment on macrophage phenotype in
prophylactic chronic model. Balb/c mice were put on a control or 1% DHA diet for 18
weeks. At weeks 2, 3, 4, & 5, mice were instilled with either DM-only, MWCNT, or SiO2
and euthanized 13 weeks later. Relative gene expression of control diet MWCNT or SiO 2
mice were normalized to control diet DM-only mice for assessment of particle effect in (A)
lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized
to corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen
tissue. Each bar within the heat maps consist of 4-5 mice for lung tissue and 4 mice for
spleen tissue.
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characteristics indicative of tissue repair and matrix deposition. These results indicated that
the prophylactic 1% DHA treatment shifted the macrophage phenotype into a repair phase
within the spleen tissue; even with a chronic inflammatory particle exposure.

4.3.4 Effect of DHA on lung histopathology
The above results confirmed that DHA decreased various inflammatory signaling cascades
within the LLF and altered the gene expression of macrophage phenotypes within tissues.
Both of which had different outcomes that were dependent upon the type of particle and
length of DHA treatment. This indicated that it would be important to determine if DHA
impacted particle-induced lung pathology. Lung tissue sections from these mice were
trichrome-stained for histological changes and airway thickness was measured. The degree
of lung disease was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect
and 4 indicating extreme lung pathology as described within Chapter 2.
When comparing the control and DHA diet-fed mice for pulmonary pathology
analysis, there was a significant increase in pulmonary inflammation of the DHA-fed mice
when exposed to MWCNT in the semi-acute model (Figure 23A). However, there were no
differences in pathology scoring compared between diets for either the DM-only or SiO2
exposure groups. When assessing airway thickness upon DHA treatment, there was a
decrease for the MWCNT-exposed group as well as significant decreases for both DMonly and SiO2-exposed mice (Figure 23B). Representative photomicrographs of these
findings are shown in Figure 23C. These results indicated that the prophylactic 1%
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Figure 23. Histopathology analysis of lung tissue in prophylactic semi-acute model. Balb/c
mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were instilled
with either DM-only, MWCNT, or SiO2 and euthanized 1 week later. (A) Pathology was
scored blinded by a board-certified veterinary pathologist, (B) airway thickness was
measured blinded, and (C) representative images (10x) of Gömöri’s trichrome-stained lung
airway sections. Data presented as mean ± SEM, n=3. *P<0.05, **P<0.01 compared to DM,
+ compared to different diet within the same exposure group. Arrows indicate particle
encapsulation, arrow heads indicate increased lung airway thickness, and blue staining
indicates collagen deposition.
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DHA treatment decreased airway thickness when compared to control mice, regardless of
a semi-acute exposure to inflammatory particles.
In the chronic model, DHA significantly decreased pulmonary inflammation with
DM-only exposure when compared to the control diet (Figure 24A) and had a
corresponding slight decrease in airway thickness (Figure 24B). DHA had a significant
increase of pulmonary inflammation for mice exposed to MWCNT compared to the control
diet-fed mice (Figure 24A) as well as trending increased airway thickness (Figure 24B).
SiO2-exposed mice on the DHA diet had increased pulmonary inflammation when
compared to the control diet (Figure 24A), but there was no change between diets when
airway thickness was assessed (Figure 24B). Representative photomicrographs of these
findings are shown in Figure 24C. These results indicated that a chronic exposure to
particles created increased inflammation; especially with SiO 2, regardless of diet. The
prophylactic 1% DHA treatment did not appear beneficial for lung histopathology at this
particular timepoint. However, it should be noted that the total particle dose was four-times
higher in the chronic exposure model compared to the semi-acute model. This may
contribute to the differences between the two exposure models where the chronic model is
more representative of a long-term occupational exposure.

4.4 Discussion
Occupational exposure to SiO2 can lead to silicosis and autoimmune diseases. In contrast,
there are no confirmed human diseases resulting from MWCNT exposures at this time.
However, both particles can lead to lung inflammation in animal models and with the
widespread use of various ENM has increase for concern. MWCNT serves as an
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Figure 24. Histopathology analysis of lung tissue in prophylactic chronic model. Balb/c
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. (A)
Pathology was scored blinded by two observers; data presented as median ± SEM. (B)
Airway thickness was measured blinded; data presented as mean ± SEM. (C)
Representative images (10x) of Masson’s trichrome-stained lung airway sections. n=3;
*P<0.05, **P<0.01, ***P<0.001 compared to DM, + compared to different diet within the
same exposure group. Arrows indicate particle encapsulation, asterisks indicate lesion
formation, and blue staining indicates collagen deposition.
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important inflammatory model since it has been reported to cause eosinophilic
inflammation linked to asthma (Carvalho et al., 2018) which also appears to be more
sensitive in female mice (Ray & Holian, 2019). The differences between the MWCNTand SiO2-exposed mice with DHA treatment throughout the current studies could be
attributed to a number of variables such as size, surface charge, surface wettability,
morphology, persistence in the lung, or even composition. MWCNT are man-made rolled
graphene sheets in the size range of 1–100 nm in at least one dimension with a high surface
area per mass and they are very hydrophobic (Saifuddin et al., 2013). SiO2, on the other
hand, is commonly found in nature as quartz which can be fractured to be a respirable size
of <10 μm and are considered hydrophilic on the surface (Dyachenko et al., 2004; Pollard,
2016). Unfortunately, established prophylactic or therapeutic treatments are lacking for
inflammatory diseases caused by these particles. The goal of these studies was to assess if
DHA; an omega-3 polyunsaturated fatty acid known to have anti-inflammatory effects,
could potentially decrease inflammation induced by MWCNT or SiO 2 in semi-acute and
chronic exposures for a wildtype murine model. Therefore; inflammatory signaling within
the LLF, lung histopathology analysis, the occurrence of LMP, and macrophage phenotype
shifts were performed in these studies.
It has been shown that exposure to MWCNT or SiO 2 causes an increase in
inflammatory cytokines as well as increased lung pathology (Pollard, 2016; Hamilton et
al., 2012; Jessop et al., 2017). Various studies have reported that feeding fish oil to mice
decreased inflammatory cytokine production, such as TNF, IL-1β, and IL-6 (Bhattacharya
et al., 2007; Calder, 2015; Xi et al., 1998). There is also evidence suggesting that DHA
treatment can protect against SiO2-triggered autoimmunity within kidney and lung tissue
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in a lupus-prone mouse model (Bates et al., 2016). Omega-3 fatty acid supplementation
demonstrated a protective effect in lung pathology when exposed to fine particulate matter
in both C57BL/6 and transgenic Fat-1 mice (X.-Y. Li et al., 2017). However, murine strains
vary in their responses and there is limited research when assessing cytokine analysis and
lung pathology for particle-induced inflammation with DHA treatment using a Balb/c
mouse model. Therefore, the current studies were designed to address that gap of
knowledge. The current results indicated a consistent decrease of inflammatory cytokine
levels within the LLF of DHA-treated mice when exposed to MWCNT in both the semiacute and chronic exposure models. A decrease in airway thickness was also observed in
the semi-acute model when exposed to MWCNT with DHA treatment. In contrast, mice
that were exposed to SiO2 with DHA treatment showed a consistent increase of most
inflammatory cytokine levels within the LLF. Lung pathology was severe regardless of
diet throughout both studies within these same mice as well. These results confirmed our
hypothesis that DHA decreased pulmonary inflammatory markers which was beneficial to
the MWCNT-exposed mice, but less obvious for SiO2-treated mice. This indicated that
DHA as a beneficial prophylactic treatment may depend upon certain inflammatory particle
exposures which could be attributed to the various physiochemical differences between the
two types of particles as mentioned above.
Exposure to MWCNT and SiO2 have been linked to LMP which mechanistically
leads to NLRP3 inflammasome activation resulting in lung inflammation. One study has
indicated that MWCNT increased NLRP3 inflammasome activation in THP-1 cells and
primary human blood monocytes (Svadlakova et al., 2020). It was also shown that
MWCNT induced HMGB1 secretion within LLF of C57BL/6 mice which contributed to
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signal 1 of NLRP3 inflammasome activation (Jessop & Holian, 2015). It is well-known
that SiO2 exposure also activates the NLRP3 inflammasome (Dostert et al., 2008; Hornung
et al., 2008). DHA treatment of THP-1 cells using LPS as a stimulus of signal 1 showed a
decrease in NLRP3 inflammasome activation (Martínez-Micaelo et al., 2016; WilliamsBey et al., 2014). The incorporation of DHA into phospholipids could alter lipid packing
and membrane raft structure in lysosomal membranes which could affect membrane
stability and LMP (Turk and Chapkin, 2013; Wassall et al., 2018). Unfortunately, there is
little mechanistic information to determine if DHA decreases particle-induced LMP,
leading to decreased NLRP3 inflammasome activation. The current studies addressed the
effects of DHA on particle-induced LMP by measuring total cathepsin release and
cathepsin B release within the LLF as well as IL-1β release from AM ex vivo. There was
no difference between diets with either particle exposure during the semi-acute model;
however, DHA did decrease LMP markers for both particle exposures in the chronic model.
This suggested that DHA could affect the phagolysosomal membrane with prolonged
treatment resulting in changes in stability that accounted for decreased IL-1β release. This
finding supported the hypothesis that DHA decreases pulmonary inflammatory markers.
It has been reported that DHA decreased M1-like macrophage-associated markers
while increasing anti-inflammatory cytokines within co-culture of adipocytes and
RAW264.7 cells (De Boer et al., 2014). Another study indicated that DHA induced a M2like polarization via the PPARγ pathway in RAW264.7 cells (Chang et al., 2015). As for
in vivo responses, C57BL/6J mice treated with DHA demonstrated that adipose tissue
macrophages polarized towards a M2a-like phenotype (Titos et al., 2011). Another in vivo
study showed that M2a markers were increased in an ischemic brain model of C57BL/6
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mice with DHA treatment (Cai et al., 2018). Much less is known about the alterations of
macrophage phenotype in regard to particle exposure as well as the impacts of DHA
treatment on these exposures. The current study aimed to determine if DHA could maintain
it’s trending M2-like shift after exposure to various particles. In the semi-acute particle
exposure model, both MWCNT and SiO2 upregulated the M1 phenotype markers in spleen
tissue; however, DHA treatment downregulated these inflammatory gene expression
markers. The chronic particle exposure model showed a trend of upregulated M2b gene
expression markers for SiO2-exposed mice with DHA treatment in the lung tissue which
could be attributed to the increased number of neutrophils found within the LLF. One study
found that neutrophil efferocytosis induced a M2b phenotype in C57BL/6 bone marrowderived macrophages (Filardy et al., 2010). The current chronic study also showed an
upregulation of M2a and M2c gene expression markers in the spleen tissue upon DHA
treatment which are indicative of tissue repair. These results indicate that DHA treatment
can downregulate inflammatory gene expression markers and upregulate pro-resolving and
tissue repair within a particle exposure model which supports our hypothesis. These results
also demonstrated that future macrophage phenotype research should not be confined to
only the M1 and M2a phenotypes.
Information on the correlations between LMP and macrophage phenotype is scarce.
It has been shown that both NLRP3 inflammasome and NOD2 were upregulated within
the M1 phenotype of peripheral blood mononuclear cell-derived macrophages following
LPS stimulation (Awad et al., 2017). Another study found that NLRP3 inflammasome
inhibition shifted macrophages to a M2c-like phenotype in a nephrocalcinosis-related
kidney disease model (Anders et al., 2018). This could potentially explain the results within
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the current study showing decreased LMP in the chronic exposure model and increased
M2c phenotype markers in the spleen tissue with DHA treatment within the same model.
One possible explanation for these differences could be linked to the coordinated lysosomal
expression and regulation (CLEAR) gene network and its gene transcription factor EB
(TFEB). TFEB silencing is associated with the downregulation of eighteen out of twentythree lysosomal genes and found to regulate cathepsin B in HeLa cells (Sardiello et al.,
2009). The knockdown of TFEB promoted M2-like polarization via STAT3 activation
within a tumor microenvironment of peritoneal macrophages (Fang et al., 2017). Our
laboratory has recently seen differences between the various macrophage phenotypes and
LMP which could correlate with alterations in TFEB.
These results suggested that DHA had a consistent anti-inflammatory effect on
MWCNT-exposed Balb/c mice in a semi-acute and chronic exposure model which is linked
to stabilizing the phagolysosomal membrane and alterations in macrophage phenotype
formation. Exposure to SiO2 with DHA treatment was not as consistent throughout the
exposure studies which indicates that DHA treatment may not be the correct fit for
excessive SiO2-induced inflammation even though there were several promising outcomes.
The findings support the notion that DHA could potentially be used as a prophylactic
treatment and should be investigated further as a possible therapeutic treatment after
particle exposure.
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Chapter 5
DHA as a potential therapeutic treatment for semi-acute and
chronic particle-induced inflammation in vivo

5.1 Abstract
Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid that has been
reported to suppress inflammation. Chronic pulmonary inflammation can be linked to
exposure of various occupational and man-made particles which can lead to pulmonary
diseases. The development of therapeutic treatments are lacking within the field of particleinduced pulmonary inflammation; therefore, this study evaluated DHA as a potential
therapeutic treatment for semi-acute and chronic particle-induced inflammation. Balb/c
mice were oropharyngeal instilled with dispersion media, a highly inflammatory multiwalled carbon nanotube (MWCNT), or crystalline silica (SiO2) at week 0 (semi-acute) or
once a week at weeks 0, 1, 2, 3 (chronic). The mice were kept on the normal mouse chow
during this time for each study. One week after the last particle instillation (week 1; semiacute, or week 4; chronic) the mice were placed on either a control or 1% DHA-containing
diet for 3 weeks (semi-acute) or 12 weeks (chronic). Either 4 weeks (semi-acute) or 13
weeks (chronic) after the last particle instillation inflammatory signaling within the lung
lavage fluid, impacts on phagolysosomal membrane permeability, shifts of macrophage
phenotype gene expression (M1, M2a, M2b, and M2c), and pulmonary histopathology
were assessed. The results indicated that DHA was more protective as a therapeutic
treatment in a chronic particle-exposure model; especially for MWCNT exposure.
Exposure to SiO2 with DHA treatment was not as consistent throughout the exposure
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studies. This indicated that the benefits of DHA treatment may depend not only upon the
duration of treatment, but also the type of inflammatory particle exposure being treated.

5.2 Introduction
Two important families of polyunsaturated fatty acids (PUFA) are omega-6 and omega-3
which encompass the essential fatty acids of linoleic and α-linolenic acids; respectively.
These essential fatty acids are converted into other fatty acids within each PUFA family
such as arachidonic (ARA) and docosahexaenoic (DHA) acids through various
desaturation and elongation steps (Calder, 2017). Unfortunately, in most Western diets
there is too much omega-6; in part due to high levels of consumption of red meat, and not
enough of omega-3 which can be improved with consumption of fatty fish. This diet leads
to an omega-6/-3 ratio of 10-20/1 where most adults intake less than 0.2 g/day of DHA
(Calder, 2017; Molendi-Coste et al., 2011). Increased ARA content is linked to
inflammation while exposure to omega-3 PUFAs; specifically DHA, has been reported to
have various anti-inflammatory capabilities (Calder, 2017; Swanson et al., 2012). Recent
research has suggested that omega-3 PUFAs suppress particle-induced pulmonary and
systemic inflammation as well (X.-Y. Li et al., 2017; Bates et al., 2016).
Respiratory diseases make up five of the thirty most common causes of death
(Forum of International Respiratory Societies, 2017). It is known that exposure to airborne
toxicants can cause acute and chronic inflammation within the lungs which can lead to
serious inflammatory diseases; such as lung fibrosis, and contribute to autoimmune
diseases (Wong et al., 2016). Two inhalable particles that are of concern are nano-sized
multi-walled carbon nanotubes (MWCNTs) and micron-sized crystalline silica (SiO2).
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MWCNTs have been linked to lung fibrosis and granuloma formation while exposure to
inhalable SiO2 particles is known to cause silicosis and autoimmune disorders (Lam et al.,
2006; Pollard, 2016). Understanding the mechanisms of lung inflammation and the
development of therapeutic treatments are lacking within the field of particle-induced
pulmonary inflammation. Evidence has suggested that DHA blocked SiO 2-triggered
autoimmunity in autoimmune disease-prone NZBWF1 mice and that omega-3 PUFAs
decreased inflammation in both C57BL/6 wild-type mice; which are Th1-prone, and a
transgenic Fat-1 murine model with a C57BL/6 background (Bates et al., 2016; X.-Y. Li
et al., 2017; Watanabe et al., 2004). However, assessing the effects of DHA treatment for
particle-induced inflammation within a Balb/c murine model; which are Th2-prone
(Watanabe et al., 2004), is currently limited.
Our laboratory recently assessed DHA as a potential prophylactic treatment in
semi-acute and chronic particle exposure models of Balb/c mice. Results indicated that
DHA had a consistent anti-inflammatory effect on MWCNT-exposed Balb/c mice in both
exposure models which could be linked to stabilizing the phagolysosomal membrane
and/or macrophage phenotype formation. Exposure to SiO2 with DHA treatment was not
as consistent throughout the exposure studies; however, there were several promising
outcomes. Those results indicated that DHA could potentially be used as a prophylactic
treatment for particle-induced inflammation.
The objectives of the current studies were to determine whether DHA could be used
as a prospective therapeutic treatment within both semi-acute and chronic particle exposure
models. Most research on DHA treatment is assessing it as a potential prophylaxis, but
research of DHA as a possible therapeutic is scarce. In reality, treatment to inflammatory
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diseases typically occurs after inflammation has ensued. Therefore, it is crucial to address
this gap of knowledge in order to understand if DHA treatment could be used as a
therapeutic for particle-induced inflammation. The hypothesis of this chapter is that DHA
will decrease pulmonary inflammatory markers in response to particle-induced
inflammation. In addition, the effects of DHA will be more effective in treating MWCNT
than SiO2 in the Balb/c exposure model.

5.3 Results
5.3.1 Effect of DHA on pulmonary cells and lung injury
A semi-acute model was used to assess the effects of DHA treatment following delivery of
a short-term particle exposure and a chronic model to simulate a prolonged DHA treatment
following a more substantial particle exposure model. The overall study designs are
depicted in Figure 25 (semi-acute; A and chronic; B). Briefly, mice were anesthetized with
isoflurane before instillation so as not to use any restraints or cause distress and then
oropharyngeal instilled once with either dispersion media-only vehicle (DM; 50 µl/mouse),
MWCNT (50 µg/mouse), or SiO2 (1 mg/mouse) at week 0 (semi-acute) or once a week at
weeks 0, 1, 2, 3 (chronic). The mice were kept on the normal mouse chow during this time
for each study. One week after the last particle instillation (week 1; semi-acute, or week 4;
chronic) the mice were placed on either a control or 1% DHA-containing diet for 3 weeks
(semi-acute) or 12 weeks (chronic). The mice were euthanized by a lethal dose of sodium
pentobarbital either 4 weeks (semi-acute) or 13
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Figure 25. Experimental designs of therapeutic semi-acute & chronic models. (A) Balb/c
mice were instilled once with either DM, MWCNT (50 µg/mouse), or SiO 2 (1 mg/mouse)
at week 0, kept on the normal mouse chow for 1 week, and then put on either a control or
1% DHA diet for 3 weeks; semi-acute. (B) Balb/c mice were instilled with either DM,
MWCNT (50 µg/mouse), or SiO2 (1 mg/mouse) once a week at weeks 0, 1, 2, 3 while on
the normal mouse chow and at week 4 were put on the control or 1% DHA diet for 12
weeks; chronic.
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T7d (OmegaQuant):
Experimental Groups

Fatty Acid
14:0
16:0
16:1 (ω-7) trans
16:1 (ω-7)
18:0
18:1 trans
18:1 (ω-9)
18:2 (ω-6) trans
18:2 (ω-6)
18:3 (ω-6)
18:3 (ω-3)
20:0
20:1 (ω-9)
20:2 (ω-6)
20:3 (ω-6)
20:4 (ω-6)
20:5 (ω-3)
22:0
22:4 (ω-6)
22:5 (ω-6)
22:5 (ω-3)
22:6 (ω-3)
24:0
24:1 (ω-9)

DM

Control Diet
MWCNT

0.23 ± 1.82E-04
28.26 ± 3.79E-03
0.06 ± 2.96E-05
0.39 ± 8.87E-04
13.00 ± 4.68E-03
0.21 ± 2.71E-04
19.56 ± 5.18E-03
0.20 ± 1.59E-04
9.29 ± 1.20E-02
0.09 ± 1.12E-04
0.09 ± 1.27E-04
0.22 ± 3.85E-04
0.55 ± 1.63E-04
0.20 ± 8.12E-05
1.02 ± 1.56E-03
17.75 ± 7.93E-03
0.05 ± 2.25E-05
0.11 ± 1.49E-04
2.03 ± 1.19E-03
2.30 ± 3.60E-04
0.24 ± 3.96E-04
3.66 ± 2.65E-03
0.24 ± 2.75E-04
0.26 ± 2.77E-04

0.16 ± 9.51E-05
26.61 ± 5.56E-03
0.06 ± 4.31E-05
0.33 ± 4.07E-04
13.56 ± 5.43E-03
0.16 ± 7.32E-05
19.09 ± 5.74E-03
0.21 ± 2.20E-04
9.21 ± 3.50E-03
0.10 ± 6.90E-05
0.09 ± 1.23E-04
0.20 ± 3.38E-04
0.57 ± 9.81E-05
0.21 ± 1.49E-04
1.19 ± 8.05E-04
18.74 ± 3.25E-03
0.06 ± 8.15E-05
0.14 ± 1.59E-04
2.15 ± 6.17E-04
2.23 ± 5.11E-04
0.30 ± 4.98E-04
4.01 ± 1.13E-03
0.32 ± 2.06E-04
0.31 ± 2.06E-04

SiO2
DM
% of fatty acid in RBC
0.14 ± 1.11E-04
0.26 ± 1.48E-04
26.78 ± 3.57E-03
29.49 ± 4.20E-03
0.06 ± 2.82E-05
0.05 ± 3.13E-05
0.34 ± 5.88E-04
0.38 ± 9.03E-04
14.01 ± 6.80E-03
12.21 ± 4.24E-03
0.19 ± 5.55E-05
0.15 ± 1.43E-04
19.06 ± 6.78E-03
17.49 ± 1.76E-03
0.21 ± 1.89E-04
0.13 ± 1.17E-04
9.06 ± 6.84E-03
10.42 ± 6.52E-03
0.08 ± 6.18E-05
0.04 ± 2.33E-05
0.09 ± 1.05E-04
0.07 ± 6.33E-05
0.21 ± 3.23E-04
0.20 ± 4.20E-04
0.56 ± 2.76E-04
0.38 ± 1.87E-04
0.20 ± 1.47E-04
0.18 ± 4.79E-05
1.26 ± 1.17E-03
1.06 ± 8.12E-04
18.48 ± 9.94E-03
7.70 ± 3.26E-03
0.05 ± 7.64E-05
1.57 ± 1.63E-03
0.13 ± 6.88E-05
0.16 ± 1.28E-04
2.08 ± 1.17E-03
0.75 ± 3.95E-04
2.38 ± 7.53E-04
0.54 ± 5.56E-04
0.26 ± 3.12E-04
0.54 ± 1.09E-04
3.74 ± 1.83E-03
15.61 ± 4.21E-03
0.30 ± 1.48E-04
0.34 ± 3.19E-04
0.33 ± 2.39E-04
0.29 ± 1.92E-04

1% DHA Diet
MWCNT

SiO2

0.35 ± 3.02E-04
29.95 ± 1.59E-03
0.05 ± 1.99E-05
0.44 ± 6.98E-04
11.12 ± 6.77E-03
0.17 ± 1.40E-04
17.99 ± 4.84E-03
0.12 ± 6.63E-05
10.45 ± 6.78E-03
0.05 ± 5.23E-05
0.08 ± 4.13E-05
0.20 ± 3.84E-04
0.39 ± 2.84E-04
0.17 ± 1.26E-04
1.03 ± 8.75E-04
7.44 ± 7.37E-03
1.79 ± 1.34E-03
0.13 ± 6.85E-05
0.71 ± 1.81E-04
0.50 ± 1.99E-04
0.55 ± 2.56E-04
15.71 ± 6.03E-03
0.33 ± 3.10E-04
0.27 ± 2.23E-04

0.34 ± 5.19E-04
30.74 ± 8.75E-04
0.07 ± 3.47E-05
0.27 ± 3.26E-04
11.72 ± 1.63E-03
0.28 ± 7.69E-05
17.77 ± 2.58E-03
0.21 ± 1.28E-04
9.78 ± 2.77E-03
0.06 ± 4.14E-05
0.13 ± 1.29E-04
0.19 ± 2.28E-04
0.44 ± 4.53E-04
0.19 ± 5.86E-05
1.03 ± 8.40E-04
8.33 ± 5.69E-03
1.44 ± 1.22E-03
0.11 ± 1.16E-04
0.79 ± 6.04E-04
0.51 ± 4.64E-04
0.52 ± 1.57E-04
14.30 ± 5.33E-03
0.45 ± 4.62E-04
0.34 ± 1.67E-04

Table 5. Fatty acid composition of red blood cells in therapeutic semi-acute model. Data
presented in a percentage as mean ± SEM, n=4.
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TC (OmegaQuant):
Experimental Groups

Fatty Acid
14:0
16:0
16:1 (ω-7) trans
16:1 (ω-7)
18:0
18:1 trans
18:1 (ω-9)
18:2 (ω-6) trans
18:2 (ω-6)
18:3 (ω-6)
18:3 (ω-3)
20:0
20:1 (ω-9)
20:2 (ω-6)
20:3 (ω-6)
20:4 (ω-6)
20:5 (ω-3)
22:0
22:4 (ω-6)
22:5 (ω-6)
22:5 (ω-3)
22:6 (ω-3)
24:0
24:1 (ω-9)

DM

Control Diet
MWCNT

0.14 ± 8.55E-05
26.40 ± 2.36E-03
0.07 ± 1.36E-04
0.42 ± 2.58E-04
13.48 ± 3.43E-03
0.15 ± 1.61E-04
19.25 ± 1.13E-03
0.16 ± 1.69E-04
7.23 ± 4.16E-03
0.06 ± 1.63E-05
0.06 ± 9.22E-05
0.17 ± 2.49E-04
0.53 ± 4.60E-04
0.15 ± 2.08E-04
1.39 ± 9.94E-04
20.89 ± 5.15E-03
0.04 ± 5.35E-05
0.14 ± 8.81E-05
2.20 ± 5.21E-04
3.90 ± 1.87E-03
0.11 ± 1.09E-04
2.44 ± 1.38E-03
0.24 ± 1.84E-04
0.37 ± 2.56E-04

0.17 ± 1.44E-04
28.04 ± 2.42E-03
0.08 ± 7.46E-05
0.40 ± 2.03E-04
13.22 ± 8.46E-03
0.20 ± 7.30E-05
19.26 ± 3.28E-03
0.17 ± 5.55E-05
6.48 ± 3.01E-03
0.07 ± 4.78E-05
0.09 ± 1.12E-04
0.18 ± 2.39E-04
0.60 ± 7.71E-04
0.15 ± 1.39E-04
1.14 ± 5.33E-04
20.02 ± 2.22E-03
0.05 ± 4.78E-05
0.11 ± 1.72E-04
2.43 ± 6.08E-04
4.10 ± 4.68E-03
0.11 ± 7.65E-05
2.27 ± 1.99E-03
0.25 ± 1.85E-04
0.39 ± 8.12E-04

DM
SiO2
% of fatty acid in RBC
0.25 ± 5.04E-05
0.17 ± 1.08E-04
30.95 ± 3.65E-03
27.63 ± 2.34E-03
0.05 ± 9.95E-05
0.09 ± 1.71E-04
0.44 ± 4.09E-04
0.36 ± 2.88E-04
12.16 ± 4.26E-03
13.29 ± 6.41E-03
0.17 ± 1.41E-04
0.19 ± 1.33E-04
18.03 ± 3.50E-03
19.28 ± 2.47E-03
0.15 ± 1.74E-04
0.18 ± 8.65E-05
8.60 ± 2.37E-03
6.93 ± 6.29E-03
0.05 ± 2.04E-05
0.06 ± 2.44E-05
0.10 ± 1.33E-04
0.11 ± 1.94E-04
0.17 ± 2.08E-04
0.19 ± 2.41E-04
0.41 ± 4.13E-04
0.59 ± 5.01E-04
0.14 ± 3.79E-05
0.16 ± 1.45E-04
1.16 ± 7.24E-04
1.12 ± 6.92E-04
4.98 ± 2.56E-03
20.04 ± 3.07E-03
2.31 ± 2.64E-03
0.05 ± 5.37E-05
0.12 ± 1.26E-04
0.12 ± 2.92E-05
0.16 ± 8.58E-05
2.53 ± 6.55E-04
0.05 ± 2.53E-05
3.75 ± 3.50E-03
0.60 ± 3.04E-04
0.12 ± 1.64E-04
18.29 ± 4.27E-03
2.39 ± 1.36E-03
0.32 ± 2.52E-04
0.26 ± 1.63E-04
0.35 ± 4.11E-04
0.39 ± 4.96E-04

1% DHA Diet
MWCNT

SiO2

0.27 ± 3.61E-05
31.70 ± 3.47E-03
0.06 ± 1.01E-04
0.47 ± 5.24E-04
11.42 ± 5.37E-03
0.12 ± 9.60E-05
18.37 ± 1.10E-03
0.12 ± 1.32E-04
8.60 ± 4.96E-03
0.04 ± 3.78E-05
0.07 ± 7.35E-05
0.15 ± 2.62E-04
0.35 ± 3.17E-04
0.13 ± 3.35E-05
1.14 ± 5.54E-04
4.87 ± 1.70E-03
2.42 ± 2.39E-03
0.08 ± 7.58E-05
0.14 ± 2.16E-04
0.04 ± 6.57E-05
0.61 ± 2.72E-04
18.39 ± 2.99E-03
0.24 ± 4.73E-04
0.22 ± 3.81E-04

0.24 ± 1.34E-04
32.43 ± 2.87E-03
0.04 ± 7.27E-05
0.39 ± 2.80E-04
11.06 ± 5.26E-03
0.12 ± 1.18E-04
18.60 ± 3.24E-03
0.09 ± 5.12E-05
8.38 ± 3.45E-03
0.03 ± 1.24E-05
0.06 ± 5.85E-05
0.15 ± 3.14E-04
0.32 ± 1.60E-04
0.13 ± 3.94E-05
1.17 ± 4.38E-04
5.19 ± 1.67E-03
2.12 ± 2.04E-03
0.08 ± 1.09E-04
0.12 ± 5.39E-05
0.03 ± 3.20E-05
0.58 ± 1.97E-04
18.30 ± 3.82E-03
0.18 ± 1.05E-04
0.20 ± 2.77E-04

Table 6. Fatty acid composition of red blood cells in therapeutic chronic model. Data
presented in a percentage as mean ± SEM, n=4.
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Figure 26. Fatty acid analysis within red blood cells for therapeutic semi-acute & chronic
models. Percentage of DHA content between control and 1% DHA diet for (A) semi-acute
and (B) chronic exposure models. Data presented as mean ± SEM, n=4. ++++P<0.0001
compared to different treatments within the same exposure group. Analyses were done with
log-transformed data.

96

weeks (chronic) after the last particle instillation. After termination of the two scenarios,
the mice were extensively evaluated to determine particle effects with and without DHA.
Confirmation of fatty acid composition within red blood cells was sent for analysis (semiacute; Table 5, and chronic; Table 6) which confirmed an increase in DHA content within
the DHA-fed mice compared to the control diet for both exposure models (Figure 26).
Whole lung lavages were performed in order to collect immune cells that reside within the
lungs and assess inflammatory responses.
Overall in the semi-acute model, the mice had a dominant increase in alveolar
macrophages (AM) regardless of diet and particle exposure (Figure 27A). Mice exposed to
SiO2 also had a slight increase in neutrophils compared to the other exposure groups.
Cellular toxicity was determined by assessing LDH levels (indicative of overall pulmonary
cell damage; Figure 27B) and protein concentration (marker for epithelial cell damage;
Figure 27C), within the lung lavage fluid (LLF). Mice on the DHA diet and exposed to
DM-only had lower background levels of lung injury markers when compared to DM-only
control diet mice indicating that DHA had a protective effect on basal health status. Mice
exposed to either MWCNT or SiO2 and treated with DHA had less overall cellular damage
within the lungs as indicated by LDH levels. However, there was a trending increase of
epithelial damage for both particle exposures with DHA treatment when compared to
control mice (Figure 27 B,C). Since there was a mixture of results for cellular toxicity with
DHA treatment, both inflammatory and pro-resolving cytokines were assessed within the
LLF to determine the effects of particles and DHA treatment on signaling responses (Figure
28). Mice exposed to MWCNT with DHA treatment had a
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Figure 27. Pulmonary cells and lung injury analysis in therapeutic semi-acute model.
Balb/c mice were instilled once with either DM, MWCNT, or SiO 2 at week 0, kept on the
normal mouse chow for 1 week, and then put on either a control or 1% DHA diet for 3
weeks. (A) Percentage of cell types were assessed via cytospins. (B) LDH and (C) protein
concentration were assessed in the LLF for lung damage. Data presented as mean ± SEM,
n=4-6. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared to
different diet within the same exposure group. Analyses were done with log-transformed
data.
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Figure 28. Cytokine analysis in therapeutic semi-acute model. Balb/c mice were instilled
once with either DM, MWCNT, or SiO2 at week 0, kept on the normal mouse chow for 1
week, and then put on either a control or 1% DHA diet for 3 weeks. Inflammatory
cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL6 were analyzed in the LLF. Data presented as mean ± SEM, n=4-6. *P<0.05, **P<0.01,
****P<0.0001 compared to DM, + compared to different diet within the same exposure
group. Analyses were done with log-transformed data.
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significant decrease in TNFα levels; however, IL-1β and IL-33 levels were increased
(Figure 28). For the pro-resolving mediators, DHA treatment increased IL-10 and IL-13
levels when mice were exposed to MWCNT compared to the control diet-fed mice. Mice
exposed to SiO2 with DHA treatment had an overall increase of inflammatory cytokines
compared to control diet-fed mice (Figure 28). These results showed that mice with a semiacute particle exposure to MWCNT while on a therapeutic 1% DHA diet had decreased
lung injury compared to the control diet; however, there was increased lung damage when
mice were exposed to SiO2 while on the same DHA diet which supported the hypothesis.
In the chronic exposure model, there were also predominantly AM present
regardless of exposure group as well as a small increase in lymphocytes (Figure 29A). Mice
exposed to MWCNT and treated with DHA had a trending decrease of overall cellular
damage as assessed by LDH levels (Figure 29B) within the LLF, but there was a slight
increase in epithelial cell damage as indicated by protein concentration (Figure 29C). This
corresponded with decreased inflammatory cytokine levels within the LLF with a slight
increase of IL-33 levels for mice exposed to MWCNT and treated with DHA (Figure 30).
Exposure to SiO2 had increased neutrophils and eosinophils in addition to AM and
lymphocytes for both diets (Figure 29A). This corresponded to increased cellular toxicity;
indicated by a significant increase in LDH levels (Figure 29B) and a slight increase in
protein concentration (Figure 29C), within the LLF of mice on the DHA diet compared to
control diet mice. Mice exposed to SiO2 and treated with DHA also had overall increased
inflammatory cytokine levels and decreased pro-resolving cytokine
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Figure 29. Pulmonary cells and lung injury analysis in therapeutic chronic model. Balb/c
mice were instilled with either DM, MWCNT, or SiO 2 once a week at weeks 0, 1, 2, 3
while on the normal mouse chow and at week 4 were put on a control or 1% DHA diet for
12 weeks. (A) Percentage of cell types were assessed via cytospins. (B) LDH and (C)
protein concentration were assessed in the LLF for lung damage. Data presented as mean
± SEM, n=4-7. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared
to different diet within the same exposure group. Analyses were done with log-transformed
data.
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Figure 30. Cytokine analysis in therapeutic chronic model. Balb/c mice were instilled with
either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 while on the normal mouse
chow and at week 4 were put on a control or 1% DHA diet for 12 weeks. Inflammatory
cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL6 were analyzed in the LLF. Data presented as mean ± SEM, n=4-7. *P<0.05, **P<0.01,
***P<0.001, ****P<0.0001 compared to DM, + compared to different diet within the same
exposure group. Analyses were done with log-transformed data.
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levels within the LLF when compared to mice on the control diet (Figure 30). These results
indicated that mice on the therapeutic 1% DHA diet with a chronic particle exposure to
MWCNT had less lung damage compared to the control-fed mice; however, the same DHA
treatment was not protective for SiO2-exposed mice which also supported the hypothesis.

5.3.2 Alteration of LMP due to DHA
As described above, AM were predominantly present within the LLF of the mice;
regardless of exposure group, for both the semi-acute and chronic exposure models.
Pulmonary macrophages are responsible for maintenance of homeostatic conditions within
the lungs. This includes regulating immune responses to inhaled foreign materials; such as
exposure to MWCNT or SiO2, by phagocytosing these foreign substances and processing
them for elimination. However, these environmental stimuli can cause lysosomal damage
which can lead to phagolysosomal membrane permeability (LMP) where various
lysosome-specific proteases; such as cathepsins, are released into the cytosol. Activation
of the NLRP3 inflammasome by these proteases, cathepsin B in particular, can occur and
ultimately IL-1β release ensues which results in various inflammatory cascades (Schroder
& Tschopp, 2010; Strowig et al., 2012). Therefore, the effects of DHA on LMP were
assessed in order to determine if DHA had impacted the stability of the phagolysosmal
membrane. AM were isolated from the LLF and cultured ex vivo in order to assess IL-1β
release specifically from AM. Total cathepsin and cathepsin B levels; lysosome-specific
proteases, were measured within the LLF as well.
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Figure 31. Assessment of LMP in therapeutic semi-acute model. Balb/c mice were instilled
once with either DM, MWCNT, or SiO2 at week 0, kept on the normal mouse chow for 1
week, and then put on either a control or 1% DHA diet for 3 weeks. LMP was assessed
through detection of (A) IL-1β release directly from AMs ex vivo, (B) cathepsin release
within the LLF, and (C) cathepsin B release within the LLF. Data presented as mean ±
SEM, n=3-6. *P<0.05, ***P<0.001 ****P<0.0001 compared to DM, + compared to different
diet within the same exposure group. Analyses were done with log-transformed data. CTS;
cathepsin.
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In the semi-acute exposure model, mice exposed to DM-only and treated with DHA
had decreased levels of all LMP markers compared to control diet-fed mice (Figure 31)
indicating that DHA improved the stability of the phagolysosomal membrane for basal
health. Mice exposed to MWCNT while on the DHA diet had a significant decrease of IL1β release ex vivo from AM (Figure 31A); however, there was a slight increase of total
cathepsin levels (Figure 31B) and no change between diets for cathepsin B release (Figure
31C) within the LLF. SiO2-exposed mice had a trending increase of IL-1β release ex vivo
from AM (Figure 31A) with no change between diets for total cathepsin release (Figure
31B), but decreased cathepsin B levels within the LLF (Figure 31C) when compared to
control-fed mice. These results suggested that mice on the therapeutic 1% DHA diet had
improved phagolysosomal membrane stability for background AM; however, results
varied depending on particle exposure within the semi-acute model. DHA treatment
appeared to be protective later in the LMP pathway since there was less IL-1β release for
MWCNT-exposed mice. Mice exposed to SiO2 with DHA treatment had a protective effect
on cathepsin B release; however, protease leakage still occurred and resulted in increased
inflammatory signaling when compared to control mice.
Results from the chronic exposure model showed decreased levels of all LMP
markers for DM-only exposed mice with DHA treatment compared to control diet-fed mice
(Figure 32) indicating improved phagolysosomal membrane stability similar to the semiacute model for basal health. Mice exposed to MWCNT and treated with DHA had
decreased release of IL-1β ex vivo from AM (Figure 32A) and a slight decrease for total
cathepsin levels in the LLF (Figure 32B) when compared to the control mice, but there was
no change between diets for cathepsin B levels (Figure 32C). SiO2-exposed mice
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Figure 32. Assessment of LMP in therapeutic chronic model. Balb/c mice were instilled
with either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 while on the normal
mouse chow and at week 4 were put on a control or 1% DHA diet for 12 weeks. LMP was
assessed through detection of (A) IL-1β release directly from AMs ex vivo, (B) cathepsin
release within the LLF, and (C) cathepsin B release within the LLF. Data presented as
mean ± SEM, n=4-7. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, +
compared to different diet within the same exposure group. Analyses were done with logtransformed data. CTS; cathepsin.
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with DHA treatment had a significant decrease of IL-1β release ex vivo from AM (Figure
32A); however, there were increased levels of both total cathepsin and cathepsin B within
the LLF (Figure 32 B,C) when compared to control diet-fed mice. These results indicated
that mice within the chronic exposure model on the therapeutic 1% DHA diet and exposed
to DM-only or MWCNT had improved phagolysosomal membrane stability. Mice exposed
to SiO2 with DHA treatment had decreased phagolysosomal membrane stability; however,
DHA was protective by decreasing AM inflammatory signaling. This supported the
hypothesis that DHA treatment decreased pulmonary inflammatory markers in response to
particle-induced inflammation which was more effective in treating MWCNT- than SiO2exposed mice.

5.3.3 DHA shifts macrophage phenotype
Recent in vivo particle-exposure studies in our laboratory using 1% DHA as a prophylactic
treatment demonstrated that mice on the DHA diet shifted macrophage phenotype towards
the pro-resolving phenotypes. Various signaling factors; such as cytokines and immune
complexes, generate different macrophage phenotypes that are broadly defined as either
classically activated, “pro-inflammatory” M1 or alternatively activated, “antiinflammatory” M2. However, a spectrum of macrophage phenotypes is always present
which could be representing hybrid phenotypes rather than individually-defined
phenotypes. Extracellular and intracellular signaling factors determine which macrophage
phenotype is dominant to regulate the overall response. Depending on the overall
environment, macrophages could either be aiding in inflammation or suppressing
inflammation through phenotype shifts (Byrne et al., 2015; Italiani & Boraschi, 2014;
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Labonte et al., 2014). It is important to understand that this is a snap-shot in time to assess
the shifts in phenotypes between particle exposure as well as DHA treatment groups at
these particular timepoints. Assessing the effects of DHA on macrophage phenotype when
exposed to various particles is lacking in the current literature; especially when analyzing
the M2b and M2c subsets. Therefore, macrophage phenotypes were assessed within the
lung and spleen tissues using sixteen known gene markers in order to determine if exposure
to particles caused phenotype shifts and if DHA treatment impacted these alterations.
Spleen tissue was included for evaluation in this portion of the study since our laboratory
has recently shown trafficking of MWCNT into the spleen resulting in changes of immune
cell populations.
In the lung tissue of the semi-acute exposure model, there was a dominant
downregulation of overall gene expression for macrophage phenotype markers for both
MWCNT and SiO2-exposed mice when the effect of particle-only exposure was assessed
compared to DM-only exposed mice (Figure 33A). The DHA diet altered this gene
expression within the lung tissue by bringing most of those same genes closer to baseline
levels (Figure 33B). Mice exposed to DM-only had a trending upregulation of the M2b
phenotype as indicated by an upregulation of two of the four genes with DHA treatment.
There were dominant baseline gene expression levels of the M2c phenotype for mice
exposed to DM-only while on the DHA diet which indicated that these gene expressions
were similar for both control- and DHA-fed mice (Figure 33B). However, this was not the
case for mice exposed to either particle upon DHA treatment which were mostly
downregulated changes in gene expression and some baseline values instead (Figure 33B).
Gene expression within the spleen tissue had a dominant downregulation of overall
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Figure 33. Impact of particle exposure and DHA treatment on macrophage phenotype in
therapeutic semi-acute model. Balb/c mice were instilled once with either DM, MWCNT,
or SiO2 at week 0, kept on the normal mouse chow for 1 week, and then put on either a
control or 1% DHA diet for 3 weeks. Relative gene expression of control diet MWCNT or
SiO2 mice were normalized to control diet DM mice for assessment of particle effect in (A)
lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized
to corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen
tissue. Each bar within the heat maps consist of 5-7 mice for lung tissue and 4-5 mice for
spleen tissue.
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macrophage phenotype markers for MWCNT-exposed mice (Figure 33C). There was a
trending upregulation in the M2a markers for SiO2-exposed mice; however, it was not
enough to describe it as a dominant macrophage phenotype shift (Figure 33C). Upon DHA
treatment within the spleen tissue, there were minor gene expression shifts; however, the
DHA diet did not alter the overall gene expression of macrophage phenotype markers
within the spleen tissue when compared to the particle-only effect (Figure 33D). DHA
treatment did downregulate the trending M2a gene expression of the particle-only effect
observed for the SiO2-exposed mice in the spleen tissue (Figure 33D). These results
indicated that particle-exposed mice on a therapeutic 1% DHA diet did not have dominant
macrophage phenotype effects in a semi-acute model; however, DHA treatment brought
gene expression levels closer to baseline within the lung tissue.
The particle-only effect in the lung tissue of the chronic particle exposure model
had an overall downregulation of gene expression within most of the macrophage
phenotype markers, regardless of particle exposure (Figure 34A). Upon DHA diet
treatment, there was a general downregulation of gene expression throughout the
macrophage phenotype markers regardless of treatment group for the lung tissue (Figure
34B). There was a trending upregulation of the M2b phenotype with SiO 2-exposed mice
within the lung tissue with DHA treatment; however, not enough to indicate it as a
dominant phenotype shift (Figure 34B). The spleen tissue assessment of the particle-only
effect showed a dominant upregulation of the M2c phenotype for both MWCNT- and SiO2exposed mice when compared to DM-only mice as indicated by upregulation of at least
three of the four genes (Figure 34C). DHA treatment altered these responses within
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Figure 34. Impact of particle exposure and DHA treatment on macrophage phenotype in
therapeutic chronic model. Balb/c mice were instilled with either DM, MWCNT, or SiO 2
once a week at weeks 0, 1, 2, 3 while on the normal mouse chow and at week 4 were put
on a control or 1% DHA diet for 12 weeks. Relative gene expression of control diet
MWCNT or SiO2 mice were normalized to control diet DM mice for assessment of particle
effect in (A) lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice
were normalized to corresponding control diet mice for assessment of diet effect in (B)
lung and (D) spleen tissue. Each bar within the heat maps consist of 5-7 mice for lung
tissue and 4-6 mice for spleen tissue.
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the spleen tissue via a dominant downregulation of gene expression levels of almost all of
the macrophage phenotype markers regardless of particle group (Figure 34D). These
results indicated that a therapeutic 1% DHA diet for chronic particle-exposed mice did not
have a dominant macrophage phenotype shift within the lung tissue; however, DHA
downregulated gene expression within the spleen tissue.

5.3.4 Effect of DHA on lung histopathology
The therapeutic 1% DHA treatment affected inflammatory signaling cascades for both the
semi-acute and chronic particle exposure models. Therefore, investigation of DHA’s
impact on particle-induced inflammation for lung pathology was assessed. Lung tissue
sections were trichrome-stained and scored for histological analysis. The degree of lung
inflammation was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect and
4 indicating extreme lung inflammation. Airway thickness was also examined since recent
studies in our laboratory using 1% DHA as a prophylactic treatment indicated particleinduced airway thickening.
Mice on the DHA diet and exposed to DM-only in the semi-acute model had a small
increase in lung inflammation compared to control diet-fed mice (Figure 35A), but there
was no difference between diets for airway thickness (Figure 35B). Both the MWCNTand SiO2-exposed mice had minor differences for both the pathology and airway thickness
analyses; however, no significant differences were observed between the diets.
Representative photomicrographs of these findings are shown in Figure 35C.
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Figure 35. Histopathology analysis of lung tissue in therapeutic semi-acute model. Balb/c
mice were instilled once with either DM, MWCNT, or SiO2 at week 0, kept on the normal
mouse chow for 1 week, and then put on either a control or 1% DHA diet for 3 weeks.
Pathology was scored blinded by two observers; data presented as median ± SEM (A).
Airway thickness was measured blinded; data presented as mean ± SEM (B).
Representative images (10x) of Masson’s trichrome-stained lung airway sections (C). n=3;
**P<0.01 compared to DM. Arrows indicate particle encapsulation, blue staining indicates
collagen deposition.
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Figure 36. Histopathology analysis of lung tissue in therapeutic chronic model. Balb/c
mice were instilled with either DM, MWCNT, or SiO 2 once a week at weeks 0, 1, 2, 3
while on the normal mouse chow and at week 4 were put on a control or 1% DHA diet for
12 weeks. Pathology was scored blinded by two observers; data presented as median ±
SEM (A). Airway thickness was measured blinded; data presented as mean ± SEM (B).
Representative images (10x) of Masson’s trichrome-stained lung airway sections (C). n=3;
*P<0.05, **P<0.01, ***P<0.001 compared to DM, + compared to different diet within the
same exposure group. Arrows indicate particle encapsulation, arrow head indicates
increased lung airway thickness, and blue staining indicates collagen deposition.

114

These results suggested that a therapeutic 1% DHA treatment had limited effects on
particle-induced inflammation and overall lung pathology for a semi-acute particle
exposure model.
For the chronic exposure model, mice exposed to MWCNT and treated with DHA
had a slight decrease of pulmonary inflammation, but no difference for airway thickness
when compared to control diet-fed mice (Figure 36 A,B). There was no difference between
diets for pulmonary inflammation of SiO2-exposed mice, but there was significantly
increased airway thickness for mice on the DHA diet. Representative photomicrographs of
these findings are shown in Figure 36C. These results indicated that a therapeutic 1% DHA
treatment had a minor impact on a chronic MWCNT exposure. A chronic exposure to SiO2
increased inflammation regardless of diet and DHA was not beneficial for lung
histopathology for this particle exposure.

5.4 Discussion
Research of how DHA; an omega-3 PUFA reported to have anti-inflammatory capabilities,
affects particle-induced lung inflammation is currently limited. Our laboratory had
previously assessed if DHA could be used as a potential prophylactic treatment for particleinduced inflammation. Those results showed that DHA treatment was more beneficial for
a nano-sized MWCNT exposure than a micron-sized SiO2 exposure which may be linked
to phagolysosomal membrane stability and macrophage phenotype shifts. Most research is
assessing the impacts of DHA as a potential prophylaxis; however, therapeutic treatments
are lacking for particle-induced inflammatory diseases as well. The goal of this chapter
was to assess if DHA could potentially assist with treatment; specifically, pulmonary
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inflammation induced by MWCNT or SiO2 in semi-acute and chronic exposure models.
Therefore, inflammatory signaling within the LLF, lung histopathology analysis, the
occurrence of LMP, and macrophage phenotype shifts were analyzed to address this issue.
Current analysis of inflammatory mediators in the LLF demonstrated that a
therapeutic 1% DHA treatment had varying results between the particle exposure models.
This continual variance of DHA’s impact between the two different types of particles could
be linked to various physiochemical particle characteristics. These variables could be due
to particle morphology, size, surface charge, or composition. MWCNT are hydrophobic
man-made rolled graphene sheets in the size range of 1–100 nm in at least one dimension
with a high surface area per mass (Saifuddin et al., 2013). SiO2, on the other hand, is
considered hydrophilic and commonly found in nature as quartz which can be fractured to
a respirable size of <10 μm (Dyachenko et al., 2004; Pollard, 2016). Overall, DHA
treatment appeared to be more protective after the MWCNT exposure rather that SiO 2
exposure which supported our hypothesis. When assessing toxicity and cytokine
production in the LLF, LDH levels as well as IFNγ and TNFα levels were consistently
decreased upon DHA treatment for MWCNT-exposed mice. This trend continued when
LMP markers were assessed. Mice exposed to MWCNT while on the DHA diet had a
decrease in IL-1β release ex vivo for both studies as well as a trending decrease of total
CTS levels within the LLF for the chronic exposure model. Furthermore, there was a
trending decrease in pulmonary inflammation within the chronic exposure model upon
DHA treatment with mice exposed to MWCNT. The length of the DHA treatment appeared
to contribute to the varying particle effects within the Balb/c mice as well.
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There was a consistency throughout the studies where prolonged treatment of DHA
was more promising for the exposure groups. Both the basal health levels; as indicated by
the DM-only exposed, and the MWCNT-exposed mice had more decreased levels of
inflammatory cytokines in the LLF upon DHA treatment for the chronic exposure model.
The differences seen between the length of DHA treatment for particle effects may partially
be due to the time it takes for DHA to equilibrate into the phospholipids. Therefore, when
DHA is used as a therapeutic treatment the particle-induced inflammation can persist for a
few weeks before beneficial effects of DHA treatment are observed. Consequently the
current semi-acute model may have required a longer timepoint for DHA treatment as a
therapeutic in order to see more beneficial effects. The extended incorporation of DHA
into phospholipids could alter lipid packing and membrane raft structure in lysosomal
membranes which could affect membrane stability and LMP (Turk and Chapkin, 2013;
Wassall et al., 2018). When comparing the two exposure models there were also more LMP
markers decreased upon DHA treatment for the chronic model. This observation continued
when macrophage phenotype was assessed which indicated a downregulation of gene
expression in the spleen tissue with DHA treatment in the chronic particle-exposure study.
These results demonstrated that prolonged treatment of DHA; especially when exposed to
MWCNT, had the best outcome rather than the semi-acute model which supported the
hypothesis. The protective mechanisms of DHA as a therapeutic treatment were still
unclear; however, future assessments of DHA’s impact on macrophage metabolism and
autophagy should be done in order to determine these potential capabilities.
Various key functions of macrophages are related to singular metabolic signatures
(Stunault et al., 2018). There is an association between PM2.5 exposure and increased
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incidence of metabolic syndrome-related diseases (R. Li et al., 2016). The metabolic
pathways are different between the macrophage phenotypes. M1 macrophages are
associated with glycolysis, disrupted Krebs cycle, and ROS production while M2a
macrophages are linked to fatty acid oxidation, lipolysis, and glutaminolysis (Stunault et
al., 2018). Macrophage deletion of Ascl1; which is an enzyme involved in fatty acid
synthesis, is associated with decreased IL-1β and TNFα (Stunault et al., 2018). In the
present chronic particle-exposure model, there were decreased levels of both of those
cytokines within the LLF after DHA treatment. The NLRP3 inflammasome regulates
glycolysis and M1 macrophages have increased glycolysis (Finucane et al., 2019). The
current results showed an increase in various M1-associated genes for chronic particle
exposure which were downregulated upon DHA treatment. However; it has been
speculated that DHA could be exerting anti-inflammatory effects through preventing
macrophage activation (Ali et al., 2016) which correlated with the current semi-acute
particle-exposure model where there was minimal macrophage phenotype shifts. This
suggested that longer exposure of DHA treatment as a therapeutic may be more beneficial
for particle-induced inflammation.
It has been suggested that M2 macrophage activation may be associated with
increased fatty acid oxidation and mitochondrial biogenesis (Benmoussa et al., 2018). One
study reported that a fish oil diet improved mitochondrial function (Shen et al., 2017). It
has been reported that the removal of damaged mitochondria via autophagy as well as the
inhibition of fatty acid synthase decreased NLRP3 inflammasome activation and IL-1β
secretion (Benmoussa et al., 2018). However, it has been suggested that impaired lysosome
function blocks autophagy (Saitoh et al., 2008). The current results showed that DM-only
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exposed mice with DHA treatment had decreased total cathepsin, cathepsin B, and IL-1β
levels which indicates increased stability of the phagolysosomal membrane. Exposure to
particles slightly altered these results which could imply impaired lysosome function;
however, the particle-exposed mice were slightly protected upon DHA treatment. One
study reported that DHA increased autophagosome formation within bone marrow-derived
macrophages (Williams-Bey et al., 2014) while another study suggested that DHA-induced
activation of p38 MAPK in U937 cells was related to autophagy (Kawano et al., 2019). It
has been shown that SiO2-exposed autophagy-deficient mice had increased lung pathology
(Jessop et al., 2016) and the current studies revealed that mice treated with DHA had some
decreased lung pathology compared to control diet-fed mice. It would be interesting to
assess the impacts of DHA on autophagy within a particle-exposure model.
Taken together, the current results indicated that a therapeutic 1% DHA treatment
has the potential to be beneficial for particle-induced inflammation; however, it did not
appear to be as effective as using it as a potential prophylaxis. These results implied that
DHA was more protective as a therapeutic treatment in a chronic particle-exposure model;
especially for MWCNT exposure. This could be linked to the time it takes for DHA to
become incorporated into phospholipids in order to stabilize the phagolysosomal
membrane as well as shifts in macrophage phenotype formation with alterations of
macrophage metabolism or autophagy. Exposure to SiO2 with DHA treatment was not as
consistent throughout the exposure studies; however, there were several promising
outcomes. DHA could potentially be used as a therapeutic treatment for particle-induced
inflammation, but should be researched further to assess the impacts on autophagy and
metabolism since these results are not fully understood.
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